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Summary 
Direct live cell analysis markers are very important for the better understanding of cellular 
processes and pathways. In this thesis we describe the development and characterization of 
live cell markers and their application to the study of interplay between chromatin epistate 
and DNA damage and repair. 
Initially, we did an in vivo characterization of γ-H2AX nanobody (heavy chain antibodies from 
alpacas) based live cell DNA double strand break marker. As so far the analysis of the post-
translational modifications of histone H2AX (γ-H2AX) involved in DNA double strands breaks, 
was not studied in living cells, we used nanobodies as a tool. These single chain nanobodies 
can be genetically encoded and fused to a fluorescent tag, which can then be used to detect 
and trace proteins and other cellular components in vivo. After in vivo characterization, we 
found that epitope recognition was competed by endogenous proteins recognzing the same 
modification (e.g., MDC1) and suffered also from alternative binding to mimicking SQ motifs 
present in proteins such as XRCC1 repair factor. 
In parallel, a novel live cell marker for DNA replication and repair was developed by targeting 
the PCNA factor using cell penetrating peptide technology. PCNA is a key protein involved in 
DNA replication and repair pathways. Cells transfected with the fluorescent fusions of PCNA 
are widely used. To prevent the need for prior transfection and circumvent the problem of 
difficult to transfect and/or short lived cells, we developed and validated a cell permeable 
PCNA interacting peptide. This is the first ever attempt in developing an instantaneous 
biomarker, which needs only seconds to label the target. 
To further extend the applicability of the cell penetrating peptide system for site specific 
labeling of any recombinant histidine tagged as well as naturally existing histidine rich 
proteins in living cells, tris-nitrilotriacetic acid (NTA) probes was used. Here, we also 
optimized a labeling protocol so that histidine tagged proteins overexpressed in cells can be 
labeled with fluorescently tagged trisNTA in fixed and living cells.  
Finally, we explored DNA damage and repair in the context of open and closed chromatin 
states achieved by incorporation of different histone H2A variants (canonical H2A versus 
H2A.Bbd). Our established replication/repair marker was used here to test its co-localization 
with replication factors like PCNA. On a first set of experiments we analyzed DNA replication. 
Our data suggested that H2A.Bbd is enriched in the sites of active DNA replication leading to 
shortened S phase duration. On a second set of experiments, H2A.Bbd-GFP expressing 
cells were found to be more sensitive than H2A-GFP when exposed to UVC, The sensitivity 
was quantified by the level of cyclobutane pyrimidine dimer (CPD). Based on these results 
we hypothesized the reason for this increased damage could be due to more open chromatin 
comprising the H2A.Bbd and, on the other hand, the decreased damage due to more 
condensed chromatin comprising H2A. Hence, for the validation of our hypothesis we 
reversed the chromatin condensation states in both stable cell lines, i.e., we induced 
condensation of the chromatin of H2A.Bbd overexpressing cell lines and decondensation of 
the chromatin of H2A. overexpressing cell lines. Subsequent CPD damage analysis 
supported our hypothesis. The open chromatin nature leading to increased DNA damage 
susceptibility and shortened S-phase corelated with phenotypic characteristics of Hodgkin 
lymphoma cells known to overexpress H2A.Bbd. 
Zusamenfassung 
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Zusamenfassung  
Zum besseren Verständnis zellulärer Prozesse ist es wichtig für Lebendzell-Experimente auf 
gute und verlässliche Marker für zelluläre Strukturen und Prozesse zurückgreifen zu können. 
In Rahmen dieser Thesis beschreiben wir die Entwicklung und Charakterisierung solcher 
Marker, die zur Untersuchung der DNA-Replikation sowie von DNA-Reparatur-Prozessen in 
lebenden Zellen verwendet werden können. Der Fokus liegt hierbei auf der Untersuchung 
von Chromatinveränderungen während der DNA-Reparatur.  
Hierfür wurde zuerst ein Nanobody (Einzeldomänen-Antikörper aus Camelidae) gegen die 
posttranslational phosphorylierte Form der Histonvariante H2AX, γ-H2AX, die als Indikator 
für DNA-Doppelstrangbrüche dient, in vivo charakterisiert. Bisher wurde der 
Phosphorylierungstatus der Histonvariante H2AX lediglich in fixierten Zellen mittels 
Immunofluoreszensfärbung untersucht. Nanobodies können rekombinant an fluoreszente 
Proteine gekoppelt werden und entsprechend genutzt werden, um Proteine oder andere 
zelluläre Bestandteile zu visualisieren. Im Zuge der in vivo Charakterisierung des γ-H2AX 
Nanobodys taten sich zwei große Probleme bei der Epitop-Erkennung auf. So wird das 
Epitop des Nanobodys kompetitiv von anderen Proteinen wie MDC1 gebunden. Außerdem 
bindet der Nanobody das von ihm erkannte SQ-Motiv auch in anderen Reparaturproteine, 
wie beispielsweise XRCC1. 
Parallel zur Nanobody-Charakterisierung wurde ein, auf zellpenetrierenden Peptiden 
basierender, Marker für Lebendzell-Studien zu DNA-Replikation und DNA-Reparatur 
entwickelt. Hierfür fokussierten wir uns auf PCNA, ein Schlüsselprotein der DNA-Replikation 
und der DNA-Reparatur welches häufig als fluoreszentes Fusions-Protein überexprimiert 
eingesetzt wird. Um die Transfektion von Zellen und die damit verbunden Probleme, wie 
schlechte Transfektionsraten und Auswirkungen auf das Zellüberleben zu umgehen, 
entwickelten wir ein zellpermeables, mit PCNA interagierendes Peptid das in Studien zu 
DNA-Replikation und DNA-Reparatur benutzt werden kann. Dabei handelte es sich um das 
erste Experiment überhaupt in dem erfolgreich ein Biomarker entwickelt wurde, der innerhalb 
von Sekunden gewünschte Zielstrukturen sichtbar macht. 
Um diese Anwendungsmöglichkeiten zellpenetrierender Peptide noch zu erweitern und 
rekombinat mit einem Histidin-Tag versehene Proteine oder natürlich Histidin-reiche Proteine 
zu markieren, wurden Nitriloessigsäure (NTA) basierte Sonden in lebenden Zellen getestet. 
Außerdem wurde ein Färbeprotokoll optimiert, um sowohl in lebenden als auch in fixierten 
Zellen überexprimierte Proteine mit Histidin-Tag und auch endogen, Histidin-reiche Proteinen 
mit Hilfe eines, an die NTA gekoppelten, fluoreszierenden Moleküls sichtbar zu machen. 
Letztlich untersuchten wir noch DNA Reparaturmechanismen im Kontext offener und 
geschlossener Chromatinregionen in denen die erst kürzlich entdeckte Isoform von Histon 
H2A, H2A.Bbd, vorkommt. Hierfür wurde der von uns etablierte Replikations- und Reparatur-
Marker benutzt um Lokalisationsstudien von endogenem PCNA durchzuführen. In einem 
ersten Experiment untersuchten wir die DNA Replikation. Hier legen unsere Daten eine 
Anreicherung von H2A.Bbd in Regionen mit aktiver DNA Replikation nahe, was in einer 
verkürzten S-Phase resultiert. In weiteren Experimenten zeigte sich, dass eine Zelllinie, die 
stabil H2A.Bbd-GFP überexprimierte, sensitiver auf UVC-Bestrahlung reagierte, als stabil 
H2A-GFP überexprimierenden Zellen, was an Hand der Level von Cyclobutan-Pyrimidn-
Dimeren (CPD) quantifiziert wurde. Dies wurde dem weniger stark kondensierten Chromatin 
in den H2A.Bbd-Zellen zugeschrieben. Um diese Hypothese zu überprüfen, wurden die 
Chromatin-Kondensationslevel der beiden Zelltypen invertiert, also eine Kondensation des 
Chromatins in H2A.Bbd-Zellen und eine Auflockerung der Chromatinstruktur in den H2A-
Zellen herbeigeführt. Die anschließende Analyse der Cyclobutan-Pyrimidin-Dimer Level 
stütze diese Hypothese. Die offene Chromatin-Struktur, die H2A.Bbd überexprimierende 
Zelle anfälliger für DNA Schäden macht sowie die verkürzte S-Phase Dauer spiegelt die 
phänotypischen Charakteristika von Hodgkin Lymphomen wieder, in denen ebenfalls eine 
H2A.Bbd-Überexpression beobachtet wird.  
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1. General Introduction  
1.1. Understanding of DNA damage and repair processes in mammalian systems  
Genome integrity is under constant threat and undergoes tremendous damage every day 
(Lindahl, 1993; Lindahl & Barnes, 2000), contributing significantly to carcinogenesis and 
mutagenesis. DNA damage may occur in several different ways, such as DNA base 
alteration, single- and double-strand breaks, and cross links, leading to genomic instability. 
All these types of damage occur as consequences of cellular physiological process (Sancar 
et al., 2004) and are perturbed by endogenous and exogenous factors (De Bont & van 
Larebeke, 2004). Such damage can occur either directly or indirectly to the DNA.  
Endogenous DNA damage is caused by several cellular processes. Oxidative DNA damage 
may be induced by reactive oxygen species (ROS) (Fang et al., 1996) which may lead to 8-
oxo-7,8-dihydroguanine (8-oxoG; Fortini et al., 2003). Lipid peroxidation processes can 
cause DNA adducts of malonaldehyde, propeno, and etheno adducts (Fang et al., 1996; 
Hecht et al., 2001; Nair et al., 1999). S-adenosyl methionine  can donate methyl groups, 
leading to the formation of methyl guanine (Rydberg & Lindahl, 1982). Apurinic and 
apyrimidic sites are formed as a result of an endogenous labile condition (Nakamura & 
Swenberg, 1999). DNA damage by carbonyl stress causes reactive carbonyl species (RCS) 
due to endogenous lipid peroxidation and glycation processes (Roberts et al., 2003; Vaca et 
al., 1998). Through redox cycling processes oestrogen metabolites can generate reactive 
radical species (Yager & Liehr, 1996).   
Some exogenous damage is induced by environmental factors like UV irradiation from the 
sun. UV-induced DNA damage results in covalent cross-links that occur in cytosine and 
thymidine residues. Cyclobutane pyrimidine dimers (CPD) and pyrimidine (6-4) pyrimidone 
photoproducts (6-4PP) are the most commonly occurring types of damage. Chemicals like 
polycyclic aromatic hydrocarbons (PAHs) are atmospheric pollutants, which generates 
damage via ROS (Toyooka & Ibuki, 2007). A short list of different DNA damage are 
illustrated in Figure 1.1. 
What these damages have in common is that they can affect cellular physiologies in a wide 
variety of ways, potentially leading to mutagenesis and cancer. Our improved understanding 
and critical detection of DNA damage can help us to understand cancer development and 
prevention.  
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Figure 1.1. Types of DNA damage. Molecular illustration of multiple types of DNA damage and their respective 
repair pathways are shown in this figure. 
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Over the past few decades, several types of methods have been developed to understand 
different types of DNA damage and their corresponding repair processes. In the following 
table we present a short list of detection methods for DNA damage.  
Table 1.1. List of DNA damage detection methodologies 
Type of damage 
 
Detection methods Reference 
 
DNA damage on a  
single cell level 
 
 
Relative number of 
3'OH end breaks 
 
 
DNA 
fragmentation 
 
 
 
 
In vivo 
footprinting  
and DNA adducts  
 
 
 
 
 
 
Region specific 
 DNA damage 
 
 
Oxidative 
damage 
 
 
 
 
Base modifications 
DNA cross links 
DNA double strand 
breaks, and single 
strand breaks 
 
Comet assay (single-cell gel 
electrophoresis) 
Fast Halo assay 
 
Random Oligonucleotide Primed 
Synthesis (ROPS) assay 
 
 
Terminal deoxyribonucleotidyl 
transferase mediated 
deoxyuridine triphosphate nick 
end labeling (TUNEL assay) 
Dielectric relaxation spectroscopy 
 
Ligation mediated PCR (LMPCR) 
Terminal transferase-dependent PCR 
(TDPCR)  
Random amplified polymorphic DNA 
(RAPD)  
Immuno-coupled PCR (ICPCR)  
 
 
 
Comet- 
Fluorescent in situ hybridization (FISH)   
 
 
HPLC-electrospray tandem mass 
spectrometry 
Gas chromatography-mass 
spectrometry (GC-MS) 
 
 
Immunological Methods  
Immuno slot blot assay  
Immunohistochemistry 
Western blot  
 
  
 
(Olive et al., 1990) 
 
(Sestili et al., 2006) 
 
(Basnakian & James, 
1996) 
 
 
(Labat-Moleur et al., 1998) 
 
 
 
(Sheu & Sheu, 2006) 
 
(Tagoh et al., 2006) 
(Komura & Riggs, 1998) 
 
(Atienzar et al., 2002) 
 
(Denissenko et al., 1994) 
 
 
 
(Spivak, 2010) 
 
 
 
(Yue et al., 2007) 
 
(Halliwell & Dizdaroglu, 
1992) 
 
 
(Karbaschi et al., 2012) 
(Santella, 1999) 
 
 
Direct and efficient identification of DNA lesions is crucial for cellular survival. Once the DNA 
damage is successfully detected, it is efficiently handed over to repair machinery system. 
The DNA damage response system requires multiple steps, which involves the lesions’ 
uncovering, treating the repair intermediates with repair factors, checkpoint activation, and 
the recovery of genetic and epigenetic information.  
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Figure 1.2. DNA repair pathways.(A) Nucleotide excision repair (NER;) (Marteijn et al., 2014), (B) Base excision 
repair (BER), (long patch repair; (Robertson et al., 2009), and (C) homologous recombination (HR) repair (Li & 
Heyer, 2008) for double strand break repair, are shown. 
The repair pathways shown in Figure 1.2 require sequential steps and specific repair proteins 
associated with them. Primarily, detection of the DNA damage is performed by proteins like 
XPC (Xeroderma pigmentosum, complementation group C) in NER, Glycosylases in BER, or 
the MRN complex (Mre11, Rad50, and Nbs1) in DNA DSB (Double strand break) repair 
pathways. Following the detection step, repair factors are recruited. Xeroderma 
pigmentosum, complementation group G, A, B (XPG, XPA, XPB), and transcription factor II 
human (TFIIH) are involved in the NER, while replication protein A (RPA) plays a role in in 
DSB repair during the excision of the damaged DNA. Resynthesis of the excised DNA strand 
is performed by polymerases δ (delta) and ε (epsilon), RFC (replication factor C), and PCNA 
(proliferating cell nuclear antigen) in both NER and BER. In the final stages of the repair 
pathways, ligase is involved in ligation of the resynthesized strand in NER, BER and in DSB 
repair. Rad 52 catalyzes the function of the Rad 51 protein that binds to the DNA and thereby 
anneals complementary single stranded DNA. 
We need to utilize a tool that helps us to understand the DNA damage and repair process 
with a high spatial/temporal resolution. Activation of different types of DNA damage, their 
corresponding pathways, and the study of repair proteins involved in them with spatio-
temporal dynamics are extensively reviewed, particularly with a focus on the use of laser 
microirradiation tools (Mortusewicz, 2007; Muster, 2014). In table 1.2 we present a 
chronological development of laser microirradiation as a tool to induce DNA damage and the 
study of repair processes. In the present work we primarily used microirradiation as a tool to 
create localized DNA damage in living cells. 
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Table 1.2. Microirradiation as a key tool for understanding repair in the context of chromatin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.2. Understanding DNA replication process in mammalian system 
During the S-phase of the cell cycle, the entire genome of a replicating cell needs to be 
duplicated. Continual synthesis of DNA takes place in a 5′ to 3′ direction on the leading 
strand and discontinued synthesis takes place in the lagging strand as shown in Figure 1.3 
 
Figure 1.3. Illustration of major factors involved in 
DNA replication. Replication takes place in three 
important steps: (i) DNA double helix is opened up 
and unwound, (ii) the template strand is prepared, 
and (newly synthesized DNA segments are finally 
assembled. 
 
 
 
 
 
 
The replication machinery involves various proteins that perform specialized functions as 
illustrated in Figure 1.3. DNA helicases (Cdc45-MCM2) confirm that each replication origin is 
initiated only once (Tognetti et al., 2014). DNA topoisomerases perfect the steady-state level 
of DNA supercoiling in order to facilitate the protein interaction (Champoux, 2001). DNA 
primase promotes the synthesis of small RNA molecules that act as primers for DNA 
polymerases (Frick & Richardson, 2001).  
Type of 
damage/repair 
Type of microirradiation Reference 
 
DNA photo lesions 
 
 
 
 
DNA Double Strand 
breaks (DSBs) 
 
 
 
UV-laser microirradiation was used to 
induce DNA damage and then 
antibodies for the relevant damage was 
used for detection 
 
Pre-sensitized cells with BrdU followed 
by UV-A light 
 
Pulsed UV-laser 
 
(Cremer et al., 1980) 
 
 
 
 
(Limoli & Ward, 1993) 
 
 
(Rogakou et al., 1999) 
 
DNA repair proteins 
recruitment to the  
microirradiated sites 
where the DNA is 
damaged 
 
Discrimination of short 
patch and long patch  
Base excision repair 
 
Live cell imaging of UV-laser induced  
DSBs  
 
Solid state diode laser 405 nm 
 
 
488 nm and 561 nm laser for 
discriminating  
short patch repair from long patch repair 
in living cells 
 
 
(Bekker-Jensen et al., 
2005) 
 
(Mortusewicz et al., 2005) 
 
(Muster, 2014) 
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Single stranded DNA binding proteins (replication protein A) safeguard the DNA to remain 
unfolded and ensures the organization of assembly and disassembly of multiprotein 
complexes (Prakash & Borgstahl, 2012). DNA polymerase (Pol) δ/ε and replication factor C 
(RFC) are the accessory factors needed for the replication fork to load the essential 
processivity factor PCNA onto the 3′-ends of newly formed DNA strands (Majka & Burgers, 
2004). Proliferating cell nuclear antigens (PCNA) are components necessary to the DNA 
replication process. The major functions of PCNA are well described in Chapter 3.2 of this 
thesis. As a consequence of DNA replications there is high probability of the formation of 
DSBs that should be accurately repaired.   
Replication forks may sometimes get stalled or broken down leading to some base lesions 
(Helleday et al., 2007). Thus DNA replication pose a potential risk; a damaged base may 
change nucleotides and single strand breaks (SSBs) may degenerate into severe DSBs, 
which require complex processing steps for precise repair. Understanding replication with the 
right method is very important for the diagnosis and treatment of several diseases that are 
associated with defective repair of replication-induced stress. (Zeman & Cimprich, 2014). 
Varieties of methods listed in Table 1. 3 are used to study this process. 
Table 1.3. Methods to study DNA replication 
Replication study 
 
Type of detection Reference 
 
In vitro analysis 
 
 
Photo affinity labeling technique  
(to study structural and functional aspects of 
protein-DNA interactions) 
 
2D gel analysis (purification of restriction 
fragments containing replication intermediates)  
 
DNA combing analysis (fork velocity, origin 
initiation rate, fork density, numbers of potential 
and utilized origins)  
(Khodyreva & Lavrik, 
2005) 
 
 
(Mesner et al., 2009) 
 
 
(Lebofsky & Bensimon, 
2003) 
 
 
In situ analysis 
 
Double label analysis (to study initiation and 
elongation rates). 
 
 
(Aten et al., 1992)   
 
In vivo analysis  
 
Fluorescent fusion proteins (to study the 
dynamics of DNA replication factories) 
 
PCNA Chromobody (to study endogenous DNA 
replication) 
 
(Leonhardt et al., 2000) 
 
 
(Burgess et al., 2012) 
 
1.3. Challenges with present methodologies to monitor DNA replication, damage, and 
repair processes 
Monitoring DNA damage and repair processes in living cells is more beneficial than other 
methods because of the importance of monitoring the repair of individual DNA lesions on a 
single cell basis. All the above-described methods in tables 1.1, 1.2, and 1.3 were used to 
understand DNA associated cellular processes. However, the methodologies mentioned in 
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Tables 1.1, 1.2, and 1.3 have potential drawbacks that have remained unaddressed so far. 
(1) Most of methodologies are in vitro, hence cannot provide real time kinetic measurements. 
(2) In live cell methods, fluorescent fusions are used, which does not allow us to investigate 
post translational modifications and is limited by spectral range. (3) Transfection efficiency is 
a big obstacle in hard to transfect cells. (4) Endogenous protein dynamics are not measured 
in living cells. Hence it has become very important to try novel methodologies with which one 
can overcome the above mentioned problems and successfully understand the cellular 
processes. An attempt to solve all of the above mentioned problems with different 
technologies is described in Chapter 3.1–3.3. 
1.4. Role of chromatin organization in DNA metabolism 
The categorization of primary, secondary, tertiary, and quaternary structures used for 
proteins is also applied to chromatin structural orders. The primary structure of chromatin is 
comprised of a beads-on-a-string structure of nucleosomes and linker DNA. Figure 1.4 
shows the primary structure of the nucleosome with the core histones. Unlike proteins that 
are made of amino acids, chromatin is comprised of repeating units of identical 
nucleosomes, and thus is expected to form highly “ordered” secondary structures (Woodcock 
& Ghosh, 2010).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4. Core histones and variants of histone H2A. (A) DNA wrapped around the histones H2A, H2B, H3, 
H4 are shown. (B) Variants of H2A (i.e., H2AX, macro H2A, and H2A. Bbd) and their enrichment regions in the 
genome and functional significance is shown here and in Table 1.4 (C) The coding region of histone macro H2A 
possesses a long C terminus acidic patch, whereas H2A.Bbd completely lacks them.  
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Table 1.4. H2A variants and their functions in context of DNA damage and repair 
 
 
 
 
 
 
 
 
 
 
 
 
The higher-order organization of the genome that leads to the formation of chromatin fibers 
and chromosomes is known to play a major role in gene regulation and global genome 
stability maintenance (Fraser & Bickmore, 2007). It is therefore expected that flaws in higher-
order chromatin and its organization can cause disease. There is a collective list of diseases 
in which alterations in histone modifications were observed, although it is not precisely 
known whether these histone alterations are just a side-effect or the major cause of the 
disease (Misteli, 2010).  
Histone H2A family is the largest among histone classes with the most variants (total 19 in 
number), coded by 26 genes. Out of these 26 genes, 9 are not part of any cluster and code 
for atypical histones like macro-H2A, H2A-Bbd (described in Chapter 3.4). They are diverse 
in sequence homology and have a functional role in DNA damage repair, transcriptional, cell 
cycle, and chromatin compaction. A few variants of histone H2A that seem to play a crucial 
role in biological processes are shown in Figure 1.4B and C and summarized in Table 1.4. 
The exact mechanistic aspects of histone H2A variant are not yet fully understood. In 
general, the carboxyl-terminus of the H2A variants interacts with the "linker" region of the 
nucleosomal DNA and histone H1, and hence variants of H2A can potentially affect the 
chromatin compaction and its stability. The chromatin compaction generally helps to protect 
the DNA from being damaged (Cann & Dellaire, 2011) and delays the repair process. In 
response to DNA damage, chromatin relaxes and increases its chromatin accessibility for 
repair factors (Rubbi & Milner, 2003). Hence it is quite reasonable to assume that H2A 
variants may have an effect on the DNA damage response. Due to its biologically significant 
role we have examined H2A and H2A.Bbd in Chapter 3.4 in the context of DNA damage 
sensitivity. 
H2A variants of 
interest 
 
Functions Reference 
 
H2AX 
 
 
 
 
 
macroH2A 
 
 
 
 
 
H2A.Bbd 
 
Evolutionarily conserved at C terminus of 
H2AX have been phosphorylated specifically 
at serine 139 on DNA double strand breaks 
 
 
Macro H2A represses transcription, regulates 
cell cycle and inhibits PARP-1 activity in 
recognizing DNA damage 
 
 
 
H2A. Bbd overexpressing cells are sensitive 
to DNA damage and the H2A.Bbd 
comprising histone are not affected by 
remodeling complex SWI/SNF during repair 
 
 
(Huang et al., 2004) 
 
 
 
 
 
(Nusinow et al., 2007) 
 
 
 
 
(Sansoni et al., 2014) 
(Menoni et al., 2007) 
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2. AIMS OF THE STUDY 
The aims of the present work can be divided into two categories (1) to develop live cell 
biomarkers to study DNA damage, repair and replication; (2) to investigate the impact of 
chromatin epistate on these processes.  
1. The first goal was to develop a γ-H2AX based live cell marker using chromobody 
technology to be used in combination with laser microirradiation technique and 
monitor phosphorylation of H2AX in living cells. 
2. The second goal was to exploit cell penetrating peptides for delivering high affinity 
PCNA binding peptides and, thus, label endogenous PCNA at sites of replication and 
repair. 
3. The third goal was to further broaden the applicability of cell penetrating peptides by 
delivering small molecular probe i.e., trisNTA and label oligohistidine containing 
proteins. 
4.       The final goal was to study the effect of chromatin condensation state, dependent on 
histone H2A variants, on replication, damage and repair and its relevance to disease. 
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3. CHAPTERS 
 
3.1. In vivo epitope recognition pitfalls affect γ-H2AX chromobody function in living 
cells 
 
This chapter has the following major contributors 
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Abstract 
As live cell analysis of post-translational modifications of histone H2AX (γ-H2AX) involved in 
DNA double strands breaks has been impossible so far, the idea of using labeled 
nanobodies (chromobodies) was conceived. Animals like llamas and camels produce single-
chain antibodies. These single-chain antibodies can be genetically encoded and fused to a 
fluorescent fusion tag. These fluorescent antigen-binding proteins called “chromobodies” can 
then be used to detect and trace proteins and other cellular components in vivo. 
Chromobodies against γ-H2AX were generated. Relevant fluorescent fusion constructs were 
transfected into living cells and DNA double strand breaks were induced in these cells by 
microirradiation with a 405 nm laser microbeam. However, some  potential epitope 
recognition problems were encountered when using γ-H2AX chromobodies in living cells. 
The present study sheds light on major pitfalls like epitope masking by endogenous MDC1 
and alternative epitope recognition by overexpressed XRCC1, which must be considered in 
the future development and screening of live cell markers.  
 
Highlights 
• γ-H2AX chromobody/binder was able to get bound to phosphorylated H2AX peptide 
in vitro. 
• In vivo conditions were not suitable for the optimal performance of the γ-H2AX binder.  
• Accessibility of γ-H2AX binder was hindered by MDC1 in vivo. 
• Unspecificity of γ-H2AX binder was triggered in the presence of XRCC1 
overexpression.
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Introduction 
Damage to the DNA in a cell is a common event generally occurring in the life of a cell due to 
exogenous factors like carcinogens, ionizing radiation, viruses, environmental factors and 
endogenous factors like age and defects in the immune system. These factors may lead to 
mutations in DNA, causing cancer and other harmful effects in the cell. Hence, the study of 
cellular DNA damage is very important and requires extensive data on the modification, 
localization and interaction of cellular components. Phosphorylation of the serine at the 139th 
residue of histone H2AX (γ-H2AX) is associated with DNA double strand breaks (Rogakou et 
al., 1998; Sharma et al., 2012). Because of its function, γ-H2AX is the most sensitive 
biomarker used to study DNA double-strand breaks (DSBs) and its subsequent repair 
processess occurring in the cell. There are already a wide variety of methods that have been 
developed to observe the molecular changes that take place during the repair of DNA DSBs, 
but their application is not suitable for live cells (Rothbauer et al., 2006). Though 
microinjection of antibodies is possible for a live cell analysis, it is not preferred due to 
antibody accessibility and potential stress induced to the cell (Adams et al., 1989). 
Fluorescent fusions allow live cell kinetic measurements but cannot be used to detect post-
translational modification. Here we introduce a novel technology, towards the aim of 
understanding DNA double strand breaks and post-translational modification (i.e., 
phosphorylation associated with H2AX in living cells). Sera of llamas and camels were found 
to have both conventional heterotetrameric and also heavy chain antibodies that lack light 
chains. These heavy chain antibodies possess a single variable domain (VHH) and two 
constant domains CH2 and CH3 (Hamers-Casterman et al., 1993). These antigen binding 
domains of heavy chain antibodies (VHH), known as nanobodies, are of small size (ca. 12-
15 kDa) and retain fully functional antigen-binding capacity. These domains of VHHs can be 
fused with fluorescent tags and subsequently expressed in living cells. These fluorescent 
antigen binding nanobodies or binders, which are called chromobodies, can be used to 
detect, trace proteins and other cellular components in vivo (Zolghadr et al., 2012). The 
convex-shaped paratope of the nanobody makes its accessibility easier in comparison with 
the flat paratope of monoclonal antibodies. Nanobodies are very stable and their highly 
soluble nature makes them easily purified on a large scale in heterologous expression 
systems (Conrath et al., 2001; Frenken et al., 2000; Salema & Fernandez, 2013). Their 
antigen binding affinities are within nanomolar range (Muyldermans & Lauwereys, 1999), 
possessing high stability in a wide spectrum of temperatures and showing very good 
resistance to chemical and thermal denaturation compared to their monoclonal counterparts 
(Arbabi Ghahroudi et al., 1997; Dumoulin et al., 2002; van der Linden et al., 1999). Based on 
the choice of the epitope, chromobodies can be used to detect endogenous factors and 
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dynamic events occurring in the living cell. In principle, any antigenic property including post-
translational modifications or non-protein structures can be detected.  
Only a single domain is involved in antigen binding, and this fragmemt (15 KDa) is fully 
functional. The small size, monomeric property, and versatile antigen binding properties of 
VHHs have made them very promising molecules for various biological applications 
(Chakravarty et al., 2014; De Meyer et al., 2014; Kirchhofer et al., 2010; Rothbauer et al., 
2008; Tang et al., 2013). To expand our present understanding of DNA DSBs, we developed 
a chromobody based γ-H2AX-binder that can specifically detect histone H2AX 
phosphorylated in the serine at residue 139. Though the γ-H2AX binder was able to bind to 
the histone γ-H2AX in vitro, its binding specificity was uncertain in vivo (i.e., in the double 
strand break environment). 
Our present study focuses on in vitro, in vivo characterization of the γ-H2AX binder and the 
potential pitfalls caused by endogenous and exogenous factors for detection of histones in 
live cells.  
 
Materials and Methods  
Quick outline for the production of chromobodies 
1. An alpaca named “Anna” was immunized with γH2AX-KLH for 49 days, and the alpaca 
“Ferdl” was immunized with non-infective HIV-capsid protein. Sera were generated by 
centrifugation of blood (2000 rpm, 10 min and 4°C). The supernatant containing sera was 
reserved in 5 ml aliquots.  
2. For the serum ELISA, 1 µg of the appropriate antigen was coated in a 96 well plate 
(Maxisorp, Thermo Scientific) and the serum was added in serial dilutions. Bound alpaca 
antibodies were further detected with HRP-conjugated anti-alpaca IgG antibody (Bethyl 
Laboratories).   
3. The isolation of B cells was performed by with a Ficoll gradient using UNI-SEPMAXI 
(NOVAmed). 
4. From B cells, RNA was extracted with TRIzol reagent (Life Technologies) according to the 
manufacturer´s protocol. 
5. From this RNA, complementary DNA (cDNA) was generated using the First-Strand cDNA 
Synthesis Kit from GE Healthcare according to the manufacturer´s protocol.  
6. VHHs were amplified by three subsequent nested PCR reactions. cDNA was used as the 
DNA template for the first PCR. 
7. The amplified product and the plasmid vector pHEN4 was restricted with specific 
restriction endonucleases producing compatible overhangs to ligate. 
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8. Electro-competent TG1 cells (Agilent) were used to generate VHH libraries. They were 
transformed by electroporation with the ligation preparations performed according to the 
manufacturer´s protocol.   
9. The transformed TG1 cells were incubated with hyperphage (Progen GmbH, Germany). 
The phage particles presenting the VHH library on their tips were collected.  
10. Solid phase panning is a conventional method to select antibody fragments. Initially 10 
µg of the antigen was coated in the immunotubes at 4°C. Phage particles were added to 
them and incubated for 1.5 hours at room temperature. 
11. The bound phages were eluted and used for reinfection of TG1 cells, which were then 
used for the subsequent panning round.  
A more detailed description of the above mentioned are extensively as described 
(Schmidthals, 2013). 
Phage ELISA 
Phage ELISA is a method used to select phage clones presenting antigen specific VHHs on 
their tips. Phage particles were prepared. Initially 1 µg of antigen was coated onto 96 well 
plates. After blocking the plates with 3% milk in PBS, phage particles were added to the 
plates coated with antigen and incubated at room temperature for 2 hours. After washing 
multiple times with PBST (0.05% Tween20), bound phages were detected with an anti M13-
HRP antibody (GE Healthcare). This procedure as described (Schmidthals 2013)  
Dot blot assay      
Dot blot analysis was performed to map the epitope of an antigen specific to VHH. Firstly 2 
µg of peptide or recombinant protein was spotted on nitrocellulose membrane and incubated 
with FITC labeled VHHs. The binding signals were obtained by scanning with a Typhoon 
Scanner and normalized against the background. Quantification of the signals was 
performed with the Image Quant software. Peptides were dissolved either in 1X PBS or 
DMSO. Protocol details were as described (Schmidthals, 2013). 
Immunoprecipitation 
For one immunoprecipitation reaction, HEK293T cells transfected with γ-H2AX binder-GFP 
were resuspended in lysis buffer (20 mM Tris/Cl pH7,5, 150 mM NaCl, 0.5 mM EDTA, 0.5% 
NP-40) plus 1 mM PMSF, 1X protease inhibitor mix (Serva), 0.5 µg/µl Dnase, and 2.5 mM 
MgCl2. The lysed solution was centrifuged and the supernatant was diluted with dilution 
buffer (20 mM Tris/Cl pH 7.5, 150 mM NaCl, 0.5 mM EDTA). Then 50 µl slurry of NHS-
activated sepharose beads covalently coupled with a VHH, as detailed by (Rothbauer et al., 
2008), were equilibrated by washing three times with dilution buffer. HEK293T cell lysate was 
added to the equilibrated beads and incubated for 4 hours at 4°C. The samples were loaded 
in an SDS-PAGE. Details were as described (Schmidthals, 2013). 
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Western Blot  
Proteins from SDS gels were transferred to a nitrocellulose membrane by semi-dry blotting at 
240 mA. The membrane was incubated for 1 hour with 3% milk powder in Tris buffered 
saline with 0.075% Tween-20 (TBST) at room temperature (RT). Primary antibody anti-GFP 
(1:1000) and anti γ-H2AX (1:1000) were incubated in 3% milk-TBST at 4°C overnight. 
Secondary antibodies (1:1000) were diluted in 3% milk-TBST and incubated for 1 hour at RT. 
The membrane was washed with TBST and treated with ECL solution and bound protein 
were detected with the Typhoon scanner. Protocol were again as described (Schmidthals 
2013) 
Cell culture and Transfection 
HeLa, HEK293, H2AX knock out, and wild-type mouse embryonic fibroblasts (MEFs) cells 
were obtained from A. Nussenzweig via Heindrich Leonhardt’s lab-LMU as explained in 
Mortusewicz et al. (2008) were used. Cells were cultured at 37°C, 5% CO2 in DMEM 
containing 50 µg/ml gentamicin supplemented with 10% FCS. For optimal growth cells were 
washed with 2 ml PBS, and 1 ml Trypsin/EDTA was added and distributed to the cell layer. 
After 3 min, once the cells were detached, 9 ml of DMEM was added to stop the enzymatic 
action of trypsin.  
For live cell analysis, cells were seeded 24 hours before transfection in a µ-8 well ibidi. For 
fixed cell analysis, cells were grown on glass cover slips. Polyethylenimine (PEI) from Sigma, 
St. Louis, MO, USA with pH 7 was used to transfect the MEFs and HEK 293 cells and PEI 
with pH 10 was used for HeLas. Hiperfect (Qiagen GmbH, Germany) was used for the 
transfection of siRNAs according to the manual instructions.  
Plasmids 
Mammalian expression constructs of γ-H2AX binder-GFP were obtained from (Chromotek 
GmbH, Munich, Germany), mRFP tagged to XRCC1 (developed by Dr. Alexander Rapp), 
were mainly used for the studies. For cloning convenience, a small region in the C-terminus 
of the XRCC1 coding region was deleted by Xho enzyme and self ligated, which was used as 
the full length mRFP-XRCC1. The N-terminal domain of mRFP-XRCC1, which is devoid of 
phosphorylation sites, was obtained by removing the sequence that starts before the 
phosphorylation site by cutting with XmaI and then self ligated further. The phospho-mutant 
of the XRCC1 (CKM) was obtained from Keith Caldecott as described in (Loizou et al. 2004). 
The CKM mutant region of the XRCC1 was restricted with XmaI and Xho and placed into the 
mRFP-XRCC1 wild type version oft he construct. MDC1-GFP plasmid was obtained from 
Anna Friedl, LMU Munich. 
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Microscopy  
Live cell experiments were performed using a confocal microscope. Confocal images were 
collected using an UltraVIEW VoX spinning disc system (Perkin Elmer) on a Nikon Ti 
microscope equipped with an oil immersion Plan-Apochromat x60/1.45 numerical aperture 
(NA) objective lens (pixel size in XY 120.45 nm/pixel) in a live-cell microscopy chamber (ACU 
control, Olympus) with a temperature of 37°C, 5% CO2, and 60% humidity. For fixed cell 
analysis, fluorescent images were obtained from a Zeiss Axiovert 200 microscope equipped 
with Plan-Apochromat x63/1.4 NA oil immersion objective lens and a CCD camera Sensicam 
(PCO). 
Irradiation experiments 
In living cells, microirradiation was carried out with a 405 nm diode laser set to maximum 
power at 100% transmission available in the Nikon Ti spinning disc microscope. Preselected 
spots of ~1 µm in diameter within the nucleus were microirradiated for 1200 ms resulting in 1 
mJ energy. Before and after microirradiation confocal image series were recorded. For fixed 
cell experiments the living cells were irradiated with an X-Ray tube (GE isovolt titan) set to 90 
kV and 19 mA filtered by a 2 mm aluminium sheet prior to fixation. The dose rate was 
controlled by DIADOS T11003 Diagnostikdosimeter and a dose of 2 Gy was achieved by 
varying the distance and duration of the irradiation. 
Knockdown experiments 
For knockdown experiments, siRNA with the sequence of sense strand 5′-
CCAGAAATCTTTATGAATAAA-3′ (Invitrogen) targeting MDC1 was used, and universal 
siRNA (Invitrogen) was used as a negative control. Hiperfect was used as a cationic lipid cell 
transfection reagent. Cells like HeLa and HEK 293 were seeded at a density of 4 × 104 
cells/well in an Ibidis 100 µm eight well slide. Transfection was carried out with 20 nM MDC1 
siRNA with γ-H2AX binder-GFP incubated up to 40–80 hours for knockdown.   
Immunofluorescence  
Cells were grown on glass coverslips, fixed in 3.7% formaldehyde for 10 minutes at room 
temperature (RT), and permeabilized for 20 minutes at RT in 0.5% triton/PBS. 
Immunofluorescence staining was performed in 4% BSA/PBS for 1 hour at RT (primary 
antibodies) and for 45 minutes at RT (secondary antibodies). The following primary 
antibodies were used: mouse anti-γ-H2AX (Clone JBW301, 1:500, Upstate), anti-MDC1 
(1:100) (Sigma Aldrich Inc, St. Louis, MO, USA). For detection, the cells were stained with 
donkey anti-mouse Alexa 488 (Jackson Immuno Research) and goat anti-mouse Cy3 
(Jackson Immuno Research). Nuclear DNA was visualized with 4,6-diamidino-2-phenylindole 
(DAPI) (Sigma-Aldrich) for 10 minutes. Cells were mounted in vectashield antifade (Vector 
Laboratories Inc). 
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Image analysis and quantification 
For evaluation of the kinetics of the accumulation of γ-H2AX binder from microirradiation 
data, a minimum of 8–10 cells were analyzed. To visualize data, normalization of the raw 
recovery curves, and fitting curves  was done by easyFRAP a matlab standalone application 
(Rapsomaniki et al., 2012). Raw intensities of bleached area (ROI1), the whole cell (ROI2), 
and a background area (ROI3) as well as the corresponding time-points are calculated using 
a custom made ImageJ macro made by Dr. Alexander Rapp (Kind et al., 2014). Results were 
saved in .csv, .txt, and .xls file formats and analyzed with easyFRAP software, which 
computes the recovery curves, according to the formula of double normalization and maximal 
accumulation representing the highest ratio from each experiment. Stepwise descriptions are 
explained in the manual (http://ccl.med.upatras.gr/data/uploads/easyfrap_manual.pdf). Foci 
of γ-H2AX/MDC1 were counted manually and confirmed with foci picker 3D, an Image J 
plug-in (Du et al., 2011).  
 
Results  
Outline on the development of γ-H2AX specific VHH 
The outline in Figure 3.1 summarizes the main steps of the nanobody generation process. 
Alpacas were immunized with specific peptides following a 7 week period, RNA from 
lymphocytes was extracted and retrotranscribed to DNA, and the sequences corresponding 
to the VHH domains were amplified with specific primers for cloning into a phage display 
vector. This library was then separately subjected to several rounds of panning on plates 
coated with the antigens (peptides). VHH clones that showed strong binding activity were 
detected with a phage-ELISA assay, and the high affinity clones were used for further 
analysis. The binding ability of VHH to γ-H2AX was tested by in vitro methods like dot blot, 
immunoprecipitation and in vivo methods like live cell assays (Figure 3.1). 
 
Figure 3.1. Schematic representation of alpaca derived γ-H2AX chromobody generation and application.   
γ-H2AX specific VHH generation, which starts from immunization of the alpacas. Production is illustrated with the 
intermediate steps, and further details are available in the text. The in vitro and in vivo characterization results of 
the γ-H2AX binder are discussed in this chapter.  
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Biochemical characterization of γ-H2AX binder/chrombody 
The γ-H2AX binder obtained by the screening methods as described above was checked for 
its binding ability in vitro (Figure 3.2). The different VHH clones were tested in vitro using 
phage ELISA, where the titre plates were coated with γ-H2AX peptides and the phage 
displaying the VHH were allowed to bind to the peptides, and the stably bound phages were 
eluted. Clones 3, 4, and 19 were selected; the experimental results with clone 3 are shown in 
this chapter (Figure 3.2B). Clone 3 was picked for immunoprecipitation experiments. The 
cells transfected with the γ-H2AX binder-GFP were treated with 50 µg neocarcinostatin 
(NCS) to generate DSBs and γ-H2AX. The cell lysate containing γ-H2AX and γ-H2AX binder 
3-GFP were expected to bind to each other, and they were allowed to bind to the GBP beads 
(Rothbauer et al., 2008). The results showed substantial binding of γ-H2AX binder 3-GFP to 
γ-H2AX.  
For the dot blot assay (Figure 3.2C) the peptides were spotted at different concentrations on 
the membrane, and the purified γ-H2AX binder 3-GFP was chemically coupled to FITC, 
allowed to bind to the peptides, and tested for its binding affinity. The γ-H2AX peptide was 
coupled to a different carrier (i.e., BSA), which was used in order to check for the affinity of 
the binder to the carrier. The γ-H2AX binder 3-FITC showed better binding to γ-H2AX 
peptide-KLH than with γ-H2AX peptide-BSA. For this reason, the immunization was 
performed with γ-H2AX peptide-KLH which has some degree of specificity generated to KLH.  
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Figure 3.2 In vitro characterization of γ-H2AX binder. (A) Phage ELISA after three rounds of panning are 
shown. In the experiment, wells were coated with γ-H2AX peptide and γ-H2AX binder displaying phage was used. 
As a positive control (PC) the HIV protein was coated, and HIV binder displaying phage were used. GFP on H2AX 
represents GFP protein coated and γ-H2AX binder, and GFP binder displaying phage were allowed to bind. The 
amount of specifically bound phage particles are found by measuring the absorbance at a wavelength of 450 nm. 
γ-H2AX binder 3 highlighted in red was used for subsequent analysis steps. (B) For immunoprecipitation 
experiments, cells expressing γ-H2AX binder 3-GFP  and GFP alone were treated with NCS. After cell lysis, the 
extract was incubated with the GBP bound beads (Rothbauer et al., 2008). The bound fraction was loaded 
seperately, and protein amounts used for this interaction determination assay were loaded as input control and 
visualized by western blotting with anti-GFP and anti-γ-H2AX. (C) In the dot blot assay, γ-H2AX binder 3-FITC 
was allowed to get bound to the multiple concentration of γ-H2AX peptide-KLH, γ-H2AX peptide-BSA, control 
peptide, and H2AX was spotted on the membrane. γ-H2AX binder 3-FITC  bound better to γ-H2AX peptide-KLH 
than to γ-H2AX peptide-BSA (data obtained from Chromotek GmbH).  
 
In vivo characterization of γ-H2AX binder 
The γ-H2AX binder was tested for its ability to mark DNA double strand breaks in living cells 
(Figure 3.3). Here we wanted to mark the phosphorylation event that occurs on the histone 
H2AX after the DNA double strand breaks.  
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Initially, the cells were transfected with γ-H2AX binder and irradiated with the 405 nm laser, 
which has been shown to create different types of DNA damage as explained by Muster 
(2014). As there was no recruitment pattern of γ-H2AX binder observed at the sites of DNA 
damage, XRCC1, (X-Ray cross complementing protein 1) was co-transfected along with the 
γ-H2AX binder and then microirradiated. XRCC1, (X-Ray cross complementing protein 1) a 
loading protein (Mortusewicz & Leonhardt, 2007) involved in base excision and single strand 
break repair in mammalian cells was used with the aim to aid its recruitment. Recruitment of 
γ-H2AX binder was observed in the presence of the XRCC1 at the microirradiated sites.  
 
Figure 3.3. γ-H2AX binder’s specificity in living cells. (A) Cells were transfected with γ-H2AX binder and were 
microirradiated with a 405 nm laser, and no recruitment was observed. (B) Cells co-transfected with XRCC1 
showed the recruitment of the γ-H2AX binder 3. (C) Kinetics of the recruitment of the γ-H2AX binder in the 
presence and absence of XRCC1 is shown. Experiments were performed with HeLa and HEK 293 cell lines and 
both showed similar effects. Mean values were plotted and the error bar (shaded) denotes standard deviation. 
The scale bar represents 5 µm. 
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To check if XRCC1 overexpression only aids the binding of γ-H2AX binder to the target or 
has a role in altering its specificity, similar experiments were performed in the H2AX 
knockout MEF cell lines (Figure S1), where XRCC1 unexpectedly triggered the unspecific 
recruitment of γ-H2AX binder at the sites of irradiation. Based on these findings two potential 
questions arise in the in vivo characterization. Why is the γ-H2AX chromobody/binder 
recruited when co-expressed with the XRCC1? Why the γ-H2AX chromobody/binder cannot 
get recruited at the sites of double strand breaks in the living cell on its own?  
 
Alternative epitope recognition of γ-H2AX binder 
In order to determine why the binder is recruited in the presence of the over expressed 
XRCC1, mutants of XRCC1 were developed. XRCC1 has been found to have multiple 
phospho sites (Figure S2A) whose serine residues are phosphorylated by CK2 (Casein 
Kinase II), a highly conserved protein serine/threonine kinase. The mutants of XRCC1 were 
obtained by first mutating the linker region between BRCT1 and BRCT2 domains, and then 
the N-terminal domain deletion mutant was obtained by deleting the linker region containing 
the phospho sites and the BRCT2 domain in the C-terminus. 
All these mutants were compared with the full length XRCC1 as shown in Figure 3.4. The 
mutants were thus developed with the aim of providing a contingency if XRCC1’s multiple 
phospho sites were misrecognized by γ-H2AX binder instead of recognising the unique 
phospho site in S(p)Q motif available in the γ-H2AX histone at the sites of DNA DSBs. From 
the results, the mutants showed mild difference in the recruitment of the γ-H2AX binder, the 
recruitment of the γ-H2AX binder was reduced slightly in the presence to XRCC1-CKM 
mutant when compared to XRCC1 full length. The γ-H2AX binder recruitment was abolished 
completely with respect to XRCC1-NTD mutant. 
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Figure 3.4. Efficiency of alternative epitope recognition (A) Cells co-transfected with XRCC1-full length 
showed strong recruitment of the γ-H2AX binder 3. (B) Cells co-transfected with XRCC1-CKM mutant showed 
less recruitment of the γ-H2AX binder. (C) Cells co-transfected with XRCC1-NTD showed no recruitment of the γ-
H2AX binder 3. (D) Kinetics of the recruitment of the γ-H2AX binder in the presence of multiple versions of 
XRCC1 are shown. Shaded error bar represents standard deviation. (E) Maximum accumulation of the γ-H2AX 
binder is provided along with the maximum accumulation of multiple XRCC1 mutants. The error bar represents  
standard deviation, and the scale bar represents 5 µm.  
 
Epitope (γ-H2AX) unmasking studies for better epitope recognition 
When the γ-H2AX binder did not recognize the phosphorylated histone H2AX, we 
hypothesized that the epitope to be recognized may have been masked by other cellular 
proteins. Hence MDC1 (Mediator of DNA damage checkpoint protein 1), a protein that binds 
to H2AX (Figure 3.5A, S3), was knocked down to determine if this improves epitope 
recognition for the γ-H2AX binder. HEK 293 cells were knocked down with MDC1 siRNA, the 
knockdown of MDC1 was checked by immunostaining the cells at different time intervals, 
specifically at the 40 and 80 hours (Figure S4). Around 72 hours, the siRNA treated cells 
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were microirradiated with a 405 nm laser. Mild recruitment of the γ-H2AX binder was 
achieved at the irradiated sites in MDC1 siRNA treated cells but not in the control siRNA 
cells (Figure 3.5B, C). 
 
 
Figure 3.5. Epitope unmasking by knocking down MDC1. (A) MDC1 binds to the tyrosine at the 142nd residue 
of phosphorylated H2AX. (B) Cells knocked down for MDC1 with its respective siRNA showed the recruitment of 
γ-H2AX binder upon microirradiation. (C) Cells mock transfected with control siRNA showed no recruitment. (D) 
Kinetics of the recruitment of the γ-H2AX binder in the presence of  MDC1 siRNA and control siRNA is shown. 
Shaded error bar represents standard deviation. Experiments were performed in HEK 293 cell lines. (E) The 
percentage of cells that showed γ-H2AX binder recruitment with MDC1 siRNA and control siRNA is shown. The 
scale bar represents 5 µm.  
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Discussion     
It has been shown that γ-H2AX binder can bind efficiently to the phosphorylated histone 
H2AX in vitro; however, the in vivo binding ability was challenged by some factors such as 
alternative epitope recognition (i.e., XRCC1) and endogenous epitope masking factor (i.e., 
MDC1). In order to determine if the binder recruitment to the desired epitope is enhanced by 
XRCC1 or if it is misleading the protein to some other site, the binder was cotransfected with 
XRCC1 in H2AX knock out and wildtype MEFs cells, where we observed the recruitment of 
the binder, which strictly should not recruit the γ-H2AX binder (Figure S1). This shows the 
unspecificity or alternative epitope recognition problem of the chromobody. However, from 
the mutation experiment results maximal accumulation of the γ-H2AX binder depends on the 
increased XRCC1 accumulation. Hence it could be concluded that the binder’s recruitment is 
propotional to the XRCC1 accumulation and XRCC1 recruitment is slightly affected by the 
phospho site mutation and completely affected by the deletion mutation. This explains how 
the binder could possibly recognize XRCC1 alternatively. The phospho sites in XRCC1 may 
possibly not be solely responsible for misrecruitment of the binder but that the in vivo 
structural conformation of XRCC1 have several sites for repair proteins to be bound thus 
triggering such recruitment (Cuneo et al., 2011). 
It has been shown that MDC1 binds to the tyrosine at the 142nd residue of the 
phosphorylated histone H2AX, (Stucki et al., 2005). It is well known that the molecular weight 
of MDC1 is ∼250 kDa. MDC1 facilitates the binding of repair proteins and initiates the 
cascade of the DNA repair process (Stewart et al., 2003; Xu & Stern, 2003). Its ability to bind 
to the histone H2AX is described in the Figure S3. This leads us to the hypothesis that the 
size of MDC1 is huge and could potentially mask the site needed for free accessibility of the 
the γ-H2AX binder. Hence knocking down of MDC1 was proposed, and this lead to the 
successful recruitment of the binder at the irradiated sites. However, when MDC1 was 
knocked down there was a mild decrease in the γ-H2AX foci numbers (Figure S4B), which 
shows that MDC1 is critical for γ-H2AX formation at high densities near DSB (Savic et al., 
2009) and also indicates why γ-H2AX binder recruitment is so low at the irradiated sites in 
the MDC1 knockdown cells. 
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Supplementary information  
 
 
 
Figure S1. Validation of alternative epitope recognition (A) H2AX wild type cells co-transfected with 
γ-H2AX binder and XRCC1 were microirradiated with 405 nm laser and the recruited is shown (B) 
H2AX knockout cell lines showed similar recruitment patterns. (C) Maximum accumulation kinetics of 
the chromobody in knockout cells in the presence of XRCC1 is shown. Mean values were plotted and 
the error bar(shades) represents the standard deviation. Scale bar represents 5 µm.
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A 
  
  
  1 MPEIRLRHVV SCSSQDSTHC AENLLKADTY RKWRAAKAGE KTISVVLQLE KEEQIHSVDI 60  
 61 GNDGSAFVEV LVGSSAGGAG EQDYEVLLVT SSFMSPSESR SGSNPNRVRM FGPDKLVRAA 120  
121 AEKRWDRVKI VCSQPYSKDS PFGLSFVRFH SPPDKDEAEA PSQKVTVTKL GQFRVKEEDE 180  
181 SANSLRPGAL FFSRINKTSP VTASDPAGPS YAAATLQASS AASSASPVSR AIGSTSKPQE 240  
241 SPKGKRKLDL NQEEKKTPSK PPAQLSPSVP KRPKLPAPTR TPATAPVPAR AQGAVTGKPR 300  
301 GEGTEPRRPR AGPEELGKIL QGVVVVLSGF QNPFRSELRD KALELGAKYR PDWTRDSTHL 360  
361 ICAFANTPKY SQVLGLGGRI VRKEWVLDCH RMRRRLPSRR YLMAGPGSSS EEDEASHSGG 420  
421 SGDEAPKLPQ KQPQTKTKPT QAAGPSSPQK PPTPEETKAA SPVLQEDIDI EGVQSEGQDN 480  
481 GAEDSGDTED ELRRVAEQKE HRLPPGQEEN GEDPYAGSTD ENTDSEEHQE PPDLPVPELP 540  
541 DFFQGKHFFL YGEFPGDERR KLIRYVTAFN GELEDYMSDR VQFVITAQEW DPSFEEALMD 600  
601 NPSLAFVRPR WIYSCNEKQK LLPHQLYGVV PQA 
 
 
B 
 
 
H2AC       MSG--RGKQGGKARAKAKSRSSRAGLQFPVGRVHRLLR--(84)--PKKTESH-KAKSK------------- 129 
H2A.J      MSG--RGKQGGKVRAKAKSRSSRAGLQFPVGRVHRLLR--(84)--PKKTESQ-KTKSK------------- 129 
H2AD       MSG--RGKQGGKARAKAKTRSSRAGLQFPVGRVHRLLR--(84)--PKKTESHHKAKGK------------- 130 
H2AE       MSG--RGKQGGKARAKAKTRSSRAGLQFPVGRVHRLLR--(84)--PKKTESHHKAKGK------------- 130 
H2Al       MSG--RGKQGGKARAKAKTRSSRAGLQFPVGRVHRLLR--(84)--PKKTESHHKAKGK------------- 130 
H2AG       MSG--RGKQGGKARAKAKTRSSRAGLQFPVGRVHRLLR--(84)--PKKTESHHKAKGK------------- 130 
H2am       MSG--RGKQGGKARAKAKTRSSRAGLQFPVGRVHRLLR--(84)--PKKTESHHKAKGK------------- 130 
H2AI       MSG--RGKQGGKARAKAKTRSSRAGLQFPVGRVHRLLR--(84)--PKKTESHHKAKGK------------- 130 
H2A.2-A    MSG--RGKQGGKARAKAKSRSSRAGLQFPVGRVHRLLR--(84)--PKKTESHHKAKGK------------- 130 
H2A.X      MSG--RGKTGGKARAKAKSRSSRAGLQFPVGRVHRLLR--(84)--PKKTSATVGPKAPSGGKKATQASQEY 143 
H2A.Z      MAGGKAGKDSGKAKTKAVSRSQRAGLQFPVGRIHRHLK—-(87)-- GKKGQQKTV-----------------128 
                 
 
Figure S2. Mapping of phospho sites. (A) Phosphorylated sites of XRCC1 mapped was using 
phosphosite mapper in N-terminal, BRCT I, BRCTI, II domain 
(http://www.phosphosite.org/homeAction.do). (B) SQ motif in KATQASQEY sequence highlighted 
uniqueness of histone H2AX than other H2A variants found by aligning H2A variants using CLUSTAL 2.1 
multiple sequence alignment various.   
Unique phospho sites of XRCC1 and H2AX 
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Figure S3. MDC1 
binding to DNA 
double strand 
breaks depends on 
H2AX. (A) H2AX wild 
type MEF cells 
transfected with 
MDC1-GFP were 
microirradiated and 
showed recruitment. 
(B) H2AX knock out 
cells transfected with 
MDC1-GFP were 
microirradiated and 
showed no 
recruitment. (C) Mean 
values were plotted 
and the error bar 
(shaded) represents 
the standard 
deviation. Scale bar 
represents 5 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4. Confirmation of MDC1 knockdown behaviour. (A) MDC1 knockdown was validated by 
immunostaining for MDC1 and the corresponding MDC1 foci were counted in MDC1 siRNA knockdown cells and 
the control siRNA cells. They were measured at different time points after irradiating them with 2 Gy X-Rays. (B) 
γ-H2AX foci were counted corresponding to the MDC1/control knockdown. Scale bar 5 µm. 
Chapter-3.2 
 33 
 
3.2. A novel cell permeable DNA replication and repair marker 
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Abstract  
Proliferating Cell Nuclear Antigen (PCNA) is a key protein in DNA replication and repair. The 
dynamics of replication and repair in live cells is usually studied introducing translational 
fusions of PCNA.  To obviate the need for transfection and bypass the problem of difficult to 
transfect and/or short lived cells, we have now developed a cell permeable replication/repair 
marker. The design of this marker has three essential molecular components: (a) an 
optimized artificial PCNA binding peptide; (b) a cell-penetrating peptide, derived from the 
HIV-1 Trans Activator of Transcription (TAT); (c) an in vivo cleavable linker, linking the two 
peptides. The resulting construct was taken up by human, hamster and mouse cells within 
minutes of addition to the media. Inside the cells, the cargo separated from the vector 
peptide and bound PCNA effectively. Both replication and repair sites could be directly 
labeled in live cells making it the first in vivo cell permeable peptide marker for these two 
fundamental cellular processes. Concurrently, we also introduced a quick peptide based 
PCNA staining method as an alternative to PCNA antibodies for immunofluorescence 
applications. In summary, we present here a versatile tool to instantaneously label repair and 
replication processes in fixed and live cells. 
 
Highlights 
• PL peptide can quickly mark the PCNA in fixed cells thus alleviating the need for 
antibodies. 
• TAT-S-S-PL-R can directly label PCNA in living cells. 
• Introduction of disulphide bridge inbetween the carrier (TAT) and the binder (PL) 
facilitated the binding of the PL to PCNA. 
• This PCNA biomarker is successfully tried in multiple species.   
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Introduction 
DNA replication and repair are the most fundamental biological processes in any known 
organism. Several factors have been evolved to control the fidelity and efficiency of these 
processes. Deregulation of any these processes can lead to several fatal diseases such as 
cancer.  
Proliferating cell nuclear antigen (PCNA) is a central molecule at the crossroads of DNA 
replication and DNA repair. Its functions include also other vital epigenetic cellular processes, 
such as chromatin remodeling, sister-chromatid cohesion and cell cycle control (Gorisch et 
al., 2008; Maga & Hubscher, 2003). It has been even suggested that PCNA could be the 
main protein that executes ‘‘decisions’’ made by p53 (Paunesku et al., 2001). Its importance 
is strongly highlighted by its structural and sequence homology between distantly evolved 
organisms such as plants and animals.  
Structurally, PCNA forms a homotrimer that encircles DNA forming a sliding clamp (Figure 
1A) that functions as a loading platform directly interacting in this way with several proteins 
involved in DNA replication and repair (Fan et al., 2004). This platform slides along DNA 
increasing the processivity of DNA polymerase delta during DNA synthesis (Bravo et al., 
1987). One important PCNA interaction partner is the tumor suppressor protein p21WAF1 
(p21). This protein controls tumor progression by inhibiting cyclin dependent kinases (CDKs) 
and directly binding to PCNA (Trimis et al., 2008). The C terminus of p21, responsible for its 
direct binding to PCNA, is well conserved among several PCNA binding partners. However, it 
is believed that p21 inhibits or disrupts cell cycle progression by having a higher PCNA 
binding affinity and competitively inhibiting the binding of other PCNA-interacting partners 
required for DNA replication. This hypothesis has led to the development of several PCNA 
binding peptides inspired in the C terminus of p21. It has been shown that synthetic peptides 
derived from p21 can arrest cell-cycle progression and even kill cancer cells (Ball et al., 
1997; Gartel & Tyner, 2002; Tunnemann et al., 2006; Warbrick et al., 1995).    
During S phase and DNA damage repair, PCNA is co-localized with sites of active DNA 
synthesis. During DNA damage repair, the excised DNA is resynthesized with the help of 
PCNA (Cardoso et al., 1993). The development of cell proliferation biomarkers in recent 
years has provided a much deeper understanding of these processes and has led to new 
clinical tools. Currently, there are two microscopy based approaches commonly used to 
visualize the PCNA in replication/repair: (a) immunofluorescence in fixed cells and (b) 
transfecting fluorescent fusions of PCNA in living cells.  
Tumor growth correlates with an increase of PCNA levels. Immunostaining is commonly 
used to quantify the expression of PCNA in tissue as a diagnostic tool. A potential pitfall in 
quantifying the levels of PCNA to diagnose tumor growth is that these levels also increase 
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during DNA repair. Therefore, the results of these tests can be easily altered by everyday 
natural factors such as sun exposure, which leads to UV induced DNA damage and other 
skin lesions. 
Immunostaining methods cannot be performed directly in live cells as it requires cellular 
fixation and permeabilization. Live cell studies, on the other hand, currently require the 
transfection of cells with fluorescent fusions of PCNA thereby visualizing the replication foci 
(Cardoso et al., 1997). These replication foci form patterns that undergo changes in 
individual cells throughout S-phase characterizing different stages of DNA synthesis as 
shown in Figure 1B. If DNA is damaged using laser microirradiation, the repair sites can also 
be detected by looking at the accumulation of recruited PCNA to the damaged sites as 
shown in Figure 1C. Successful markers for cell cycle analysis have already made use of 
these DNA constructs expressing PCNA fluorescent fusion tags (Easwaran et al., 2005). A 
critical limitation of this approach is that cells need to be expressing the fluorescently labeled 
PCNA fusion protein. This causes a time delay and is not possible or efficient in primary cells 
or otherwise difficult to transfect cells. 
Here we present the design of an instantaneous live cell replication and repair marker. This 
design is based on three key components: (a) a high affinity PCNA interacting peptide (PIP), 
(b) a cell-penetrating peptide (CPP) to transport the PIP into the cells, and (c) an intracellular 
cleavable linker between the two peptides, so that the PIP can get uncoupled from the CPP 
after reaching the interior of the cells. We first present the rationale of the peptide design. 
Then we show its uptake in live mammalian cells instantaneously labeling repair and 
replication sites.  
 
Material and methods  
Peptides 
Peptides used for this study (Table 3.1) were synthesized by Biosyntan GmbH (Berlin, 
Germany). TAMRA-5-tetramethylrhodamine and FITC-fluorescein-isothiocyanate were the 
fluorophores used for labeling the peptides. Peptide stock solutions were prepared by 
dissolving the lyophilized peptides in deionized autoclaved water. 
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Table 3.1. Summary of Peptides 
Name Sequence 
F-p21           FITC-Ahx-KRRQTSMTDFYHSKRRLIFS 
F-p21-08           FITC-Ahx-KRRQTSITDFFHSKRRL 
F-PL           FITC-Ahx-SAVLQKKITDYFHPKK 
F-TAT-p21-08  FITC-GRKKRRQRRRAAAKRRQTSITDFFHSKRRL  
TAT(-SS-)p21-08-F       GRKKRRQRRR-C                  C-KRRQTSITDFFHSKRRL-K(FITC) 
R-TAT(-SS-)p21-08-F TAMRA-GRKKRRQRRR-C                  C-KRRQTSITDFFHSKRRL-K(FITC) 
TAT(-SS-)PL-R       RRRQRRKKRG-C                  C-SAVLQKKITDYFHPKKG-EDA-TAMRA 
 
The fluorophores 5,6-carboxytetramethylrhodamine (TAMRA) and fluorescein-isothiocyanate 
(FITC) were used for labeling the peptides. PIP refers to PCNA interacting peptides. FITC is 
coupled to N terminus through aminohexanoic acid (Ahx). (-SS-) refers to disulfide bridge. 
Plasmids 
Mammalian expression constructs encoding translational fusions of GFP-PCNA, RFP-PCNA 
were described in (Leonhardt et al., 2000) and (Sporbert et al., 2005). pFRT-B-OPCNA was 
generated from pEF5/FRT/V5 Topo (Invitrogen) by replacing hygromycin with blasticidin and 
inserting Orange-PCNA after the EF1 alpha promoter. 
Cells, culture, transfection and microinjection 
Human cell line HeLa was cultured in Dulbecco’s modified eagle medium (DMEM) and 
HaCaT with Roswell Park Memorial Institute (RPMI) 1640 medium, both supplemented with 
10% fetal calf serum, 50 µg/ml gentamicin and 2 mM glutamine. Mouse myoblasts C2C12 
(Yaffe & Saxel, 1977)  cells were cultured in DMEM supplemented with 20% fetal calf serum, 
50 µg /ml gentamicin and 2 mM glutamine. Mouse 3T3 fibroblasts stably expressing Orange 
tagged PCNA were generated by Flp recombinase mediated site specific integration of 
pFRT-B-OPCNA in Flp-In-3T3TM cells (Invitrogen) according to the manufacturer’s 
instructions. Stable clones were selected with blasticidin 2.5 µg/ml in 10% fetal calf serum, 
50 µg/ml gentamicin and 2mM glutamine. Baby hamster kidney cell line was grown in 
Glasgow minimal essential medium supplemented with 10% fetal calf serum, 50 µg/ml 
gentamicin, 2 mM glutamine and 150 µg/ml hygromycin B as previously described 
(Tsukamoto et al., 2000).  
All cell culture media was purchased from Sigma-Aldrich (Steinheim, Germany). All the cell 
lines were grown at 37° C in a humidified atmosphere with 5% CO2. For transfecting the cells 
polyethylenimine was used as previously described. (Casas-Delucchi et al., 2012). 
Microinjection of the peptides was performed using an Eppendorf microinjection and 
micromanipulation system mounted on a Zeiss LSM510Meta confocal microscope. All the 
peptides were diluted to 100 µM in PBS and injected into the cells. The parameters for 
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cytoplasmic microinjection are two seconds injection with 50 fPa injection pressure and a 
constant back pressure of 20 fPa, i.e. 30 fPa final injection pressure. 
Fluorescent labeling with PIP 
Cells were fixed with 3.7% formaldehyde for seven minutes at room temperature. They were 
permeabilized with 0.5% Triton X-100 for 15 minutes and washed with PBS. Fluorescently 
labeled PL peptide was diluted to 13 µM final concentration with PBS, added to the fixed 
cells, incubated for 30 minutes at room temperature and washed with ice cold PBS gently. 
Hence replication and repair sites can be directly visualized in fixed cells without the need of 
PCNA antibodies. In case of staining for multiple epitopes, normal immunostaining procedure 
was followed with other antibodies and then the peptide PIP was added followed by 5 
minutes post-fixation with 3.5% formaldehyde. The 4',6-diamidino-2-phenylindole (DAPI) was 
used to stain the DNA content. The coverslips can be mounted in Mowiol 4-88 (Sigma-
Aldrich Chemie). PIP binding is not stable to extensive washes when used in combination 
with other antibody stainings. It should be added at the end avoiding further washes. 
Molecular dynamics simulations 
Molecular dynamics simulations were performed using the GROMACS package, version 
4.5.6 (Pronk et al., 2013), and the Amber ff99SB (Lindorff-Larsen et al., 2010) force field. The 
temperature of the system was kept constant, coupling independently each group of 
molecules at 300 K with a v-rescale thermostat. The pressure was coupled to a Berendsen 
barostat at 1 atm isotropically. The temperature and pressure time constants of the coupling 
were 0.2 and 2 ps, respectively. The integration of the equations of motion was performed by 
using a leap frog algorithm with a time step of 2 fs. Periodic boundary conditions were 
implemented in all systems. A cutoff of 1 nm was implemented for the Lennard–Jones 
interactions and the direct space part of the Ewald sum for Coulombic interactions. The 
Fourier space part of the Ewald splitting was computed by using the particle-mesh Ewald 
method, with a grid length of 0.11 nm and using a cubic spline interpolation. The systems 
were composed of a PCNA monomer, one peptide, 15000 water molecules and potassium 
ions to neutralize the total electric charge of each system. The PCNA crystal structure 
conformation 1VYM (Lindorff-Larsen et al., 2010) from the protein data bank was used as the 
initial conformation of the PCNA monomer. The PCNA monomer was placed at the center of 
a cubic periodically replicated simulation box and the peptides were placed in a stretched 
conformation at a corner of each box. The total simulation time for each system expanded 2 
µs. (Simulation protocol written and performed by Henry David Herce) 
Live cell peptide uptake, microscopy and microirradiation 
Peptides were further diluted in DMEM medium (SIGMA-Aldrich, Steinem, Germany) to a 
final concentration of 15 µM and directly added to the cells. To visualize the DNA replication, 
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cells expressing fluorescently tagged PCNA or not were directly imaged. Whereas for 
visualizing the DNA repair sites, damage was induced by selecting specific spots in the 
nucleus of the cells and microirradiating with a 405 nm laser as previously described 
(Mortusewicz & Leonhardt, 2007). After the laser induced DNA damage, peptides at a 
concentration of 15 µM were added to the cells and the recruitment of the peptide at the 
repair site was monitored. Imaging for longer time points (> 10 minutes) requires removal of 
the peptides followed by the addition of growth media to prevent excess uptake by the cells 
which is preferentially adopted for repair experiments. Confocal microscopic images were 
collected using an Ultra VIEW VoX spinning disc system (Perkin Elmer) or on a Nikon Ti 
microscope equipped with an oil immersion Plan-Apochromat ×60/1.45 NA objective lens 
(pixel size in XY = 111 nm, Z-step = 0.3–1 µm) with laser lines at 405 nm, 488 nm, 561 nm. 
During this time cells were kept in closed chamber designed to fit the microscopy stage at 
37° C in a humidified atmosphere with 5% CO2 using the ACU control system from Olympus. 
Microirradiation experiments were carried out with 405 nm diode laser set to maximum power 
at 100% transmission available in Nikon Ti spinning disc microscope. Preselected spots of 1 
µm in diameter within the nucleus were microirradiated for 1.2 s. Prebleach and post bleach 
images were recorded based on the individual peptide recruitment kinetics. 
 
Results 
Live cell assay for the visualization of DNA replication and repair 
All replication and repair factors seem to bind to a common region in PCNA, more specifically 
the p21 protein binds at the PCNA inter-domain connecting loop located within the area 
encircled with dotted lines in Figure 3.6A. The dual role of PCNA in replication/repair was 
visualized in living cells by transfecting fluorescent fusions of PCNA. In Figure 3.6B are 
shown different stages of S phase progression that form distinctive PCNA replication 
patterns. These characteristic replication patterns might arise as a consequence of higher 
order chromatin architecture and a timely orchestrated order in which chromatin is replicated. 
Early replication patterns represent actively transcribed euchromatin, whereas late replication 
patterns are associated with heterochromatic regions (Chagin et al., 2010). Laser 
microirradiation produces significant DNA damage leading to high PCNA recruitment at the 
irradiated sites as shown in Figure 3.6C. Here, we used this live cell assay, for DNA 
replication and repair using fluorescent tagged PCNA constructs, to directly test the cell 
permeability and PCNA binding ability of PIPs.  
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Figure 3.6. PCNA marks 
DNA replication and 
repair sites. (A) Crystal 
structure of PCNA (green) 
encircling the DNA (red) 
(PDB 1AXC). PCNA 
serves as a loading 
platform for several repair 
and replication factors that 
bind to a common PCNA 
region indicated with a 
dotted line. (B) During the 
DNA synthesis phase (S-
phase) PCNA is recruited 
to sub-nuclear sites of 
DNA replication forming 
distinctive patterns over 
time that characterize 
different S-phase stages 
(shown schematically and 
with confocal images of 
GFP-PCNA expressing 
cells). (C) PCNA 
associates with sites of 
DNA damage induced by 
laser microirradiation. 
Scale bar 5 µm. 
 
 
 
 
 
 
 
 
 
 
Strategy behind the design of PCNA interacting peptides 
p21 contains a minimal consensus motif critical for its binding to PCNA, also called PIP-box 
(PCNA interacting protein or peptide), consisting of Q X X (h) X X (a) (a), where Q represents 
glutamine amino acid, X is any amino acid, (h) a moderately hydrophobic amino acid, and (a) 
aromatic residues with highly hydrophobic side chains (Warbrick et al., 1998). The p21139-160 
peptide might be evolutionarily optimized to have higher affinity for PCNA than other 
replication factors. Therefore, we decided to optimize this peptide by searching for a 
consensus PIP-box motif as shown in Figure 3.7. We compared the PIP-box of p21, DNA 
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ligase 1 and Pogo, mutated M147 for I and Y151 for F. The LIFS sequence, p21157-160, is also 
required to bind with CDK-cyclin complexes (Gartel et al., 2002; Kontopidis et al., 2005). 
Since we were interested in targeting exclusively PCNA, to avoid unspecific binding with 
CDK-cyclin we removed the IFS sequence (p21158-160). The resulting new consensus peptide 
was named p21-08 (Figure 3.7). Using the same set of sequences, p21141-160, DNA ligase I, 
and Pogo DNA transposase, a peptide called PL (Pogo-Ligase) (Kontopidis et al., 2005; 
Zheleva et al., 2000) was already reported. PL binds to PCNA with an affinity very similar to 
that of the p21141-160 peptide. The PL peptide was obtained from the sequence of DNA ligase 
I and Pogo. Therefore, we used those two sequences to optimize instead p21141-157   obtaining 
p21-08 (Figure 3.7). The PL and the newly derived consensus peptide p21-08 are the two 
PIP sequences we selected for the design of cell-permeable PCNA binding peptides to mark 
DNA repair and replication sites.  
 
Figure 3.7. Design of PCNA interacting peptides (PIP).  The red box highlights the residues binding to the 
PCNA binding pocket. The dotted lines indicate the consensus mutations introduced on the p21141-157 peptide to 
optimize the PIP-box sequence and obtain the p21-08 peptide. The IFS (p21158-160) sequence from p21 was 
removed to reduce the binding between the p21-08 and the CDK-cyclin and make its binding more selective 
towards PCNA. Additionally a previously described (Kontopidis et al., 2005) synthetic peptide PL derived from 
Pogo and DNA ligase I was used.  
 
First we asked if these peptides would label replication sites in living cells. In Figure 3.8A are 
shown the sequences of these PIPs including the wild type p21141-160 peptide and the crystal 
structure of p21139-160 bound to PCNA (PDB ID 1AXC) (Gulbis et al., 1996). In Figure 3.8B we 
show structures of all these peptides interacting with a PCNA monomer obtained from 
molecular dynamics simulations. In these simulations we found that the wild type p21141-160, 
the p21-08 and the PL all got bound to PCNA. More specifically, all these peptides motifs 
spontaneously bound at distinctive regions of the inter domain connecting loop, PCNA119–133, 
which is critical for the binding of repair and replication factors. We microinjected these 
peptides and found that all of them can label PCNA at replication sites in live cells (Figure 
3.8C). This confirmed that the in vitro derived PL peptide and the new p21-08 peptide can 
bind to PCNA and labeled replication sites when coupled to a fluorescent tag. Next we asked 
if any of these labeled peptides would be cell permeable and enter into live cells. We found 
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that when added to the extracellular media, none of these peptides were able to 
spontaneously cross the cell membrane, and label PCNA (Figure 3.8D). 
 
Figure 3.8. PCNA interacting peptides bind to PCNA in vivo but are not cell permeable. (A) Crystal structure 
of the PCNA trimer (green) with the C-terminus region of the p21 protein bound (red) to it (PDB ID 1AXC). The 
sequences of the p21 peptide and the two highest PCNA binding affinity peptides p21-08 and PL screened are 
displayed. (B) Structures of the p21 peptides and the two PIPs  i.e., p21-08 and PL  sequences obtained from 
molecular dynamics simulations are shown. (C) Images showing that these peptides [[F-p21], [F-p21-08], [F-PL]] 
after microinjection clearly co-localize with GFP-PCNA at replication sites. (D) When the peptides are added to 
the extracellular media they are not able to enter the cells. The abbreviations PC stands for phase contrast and 
DIC for differential interference contrast. Scale bar 5 µm. (Simulations from Henry David Herce and Microinjection 
data from Gisela Laettig Tuennemann) 
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Development of cell permeable PIPs to label replication/repair sites 
These peptides need to efficiently cross the cell membrane in order to label replication and 
repair sites in living cells when added to the extracellular media. It has been shown that cell-
penetrating peptides (CPP) efficiently and spontaneously enter live cells transporting other 
cargo molecules such as peptides (Tunnemann et al., 2006). Therefore, to make the PIPs 
membrane permeable we first covalently coupled the p21-08 PIP to a CPP derived from the 
HIV-1 TAT protein (TAT peptide) able to transduce into live cells and transport other peptides 
(Frankel & Pabo, 1988; Herce et al., 2013; Herce & Garcia, 2007; Lattig-Tunnemann et al., 
2011). The nucleus of a cell expressing fluorescently labeled PCNA was microirradiated 
recruiting PCNA to the damaged site. Fusion of the PIP with the CPP made the PIP cell 
permeable. However, the CPP sequence interfered with the PIP binding to PCNA (Figure 
3.9A). Coupling the PIP to a CPP can potentially interfere with PCNA binding or mistarget the 
peptide to the nucleolus, which is a known feature of arginine rich peptides (Lattig-
Tunnemann et al., 2011; Martin et al., 2007). This was solved by coupling the PIP to the CPP 
through a disulfide bridge. This disulfide bridge can be reduced in the reducing environment 
of the cytosol thereby uncoupling the active peptide (PIP) from the CPP (Figure 3.9B). To 
test this coupling design we labeled the CPP with TAMRA and the PIP with FITC. If both 
peptides get uncoupled in the cytosol, the fluorescent label in each peptide should display a 
different and distinctive intracellular distribution. Importantly, the uncoupled PIP peptide 
should be recruited by PCNA. To test this idea we delivered the peptide into laser 
microirradiated cells (Figure 3.9C). It can be seen that the PIP peptide accumulated at 
microirradiated sites, whereas the CPP distributed mainly in the cytosol and nucleolus. This 
shows that the TAT peptide was able to transport the PIP peptide into the cells, once inside 
the cells the PIP peptide was uncoupled from the carrier and freely bound to PCNA. The 
uncoupling step seemed to be crucial for the PIP binding to PCNA, since only the decoupled 
PIP was recruited to the microirradiated site (only the PIP fluorescent signal increases at the 
microirradiated sites). Although this PIP (p21-08) was able to label repair sites we did not 
detect PCNA labeling at replication sites (Figure S1). 
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Figure 3.9. Rationale to develop a cell 
permeable DNA replication and repair marker by 
targeting PCNA. (A) The nucleus of a cell 
expressing fluorescently labeled PCNA was 
microirradiated. PCNA is recruited to damaged DNA 
sites. Fusion of the PIP with a CPP [F -TAT-p21-08] 
makes it cell permeable. However, the CPP 
sequence interferes with the PIP binding to PCNA. 
(B) Design strategy: the PIP is coupled to a cell-
penetrating peptide (in this case the TAT peptide) 
via a disulfide bridge; after transporting the PIP into 
the cell the disulfide bridge is reduced; the CPP 
accumulates mainly in the cytosol and nucleolus, 
while the PIP is free to reach and bind PCNA. (C) 
To visualize in live cells the separation of the PIP 
from CPP, we labeled each sequence with a 
different fluorescent dye. The TAT peptide labeled 
with TAMRA is coupled by a disulfide bridge to the 
PIP peptide labeled with FITC [R-TAT(-SS-)p21-08-
F]. It can be seen that the free PIP labels the site of 
DNA damage, whereas the CPP distributes mainly 
in the cytosol and nucleolus.  Scale bar 5 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PIP labels DNA repair and replication sites in live/fixed cells 
Next, we applied the same CPP coupling design for the PL sequence (Figure 3.9B). We 
coupled the labeled PL peptide through a disulfide bridge to the CPP and added it to the 
extracellular media of live cells. In Figure 3.10 it can be seen that the PIP fluorescence signal 
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colocalizes with PCNA at laser microirradiated sites in live cells transfected with GFP tagged 
PCNA. Therefore, the in vivo cleaved PIP marks repair sites. 
 
 
Figure 3.10. In vivo immediate labeling of DNA repair sites. Cartoon representation of the experimental 
protocol and time-lapse snapshots obtained using confocal microscopy are illustrated. GFP tagged PCNA 
expressing cells were microirradiated. The PL peptide fluorescently labeled and coupled by a disulfide bridge to 
the TAT peptide [TAT(-SS-)PL-R]  was added to the extracellular media. PIP labels PCNA at repair sites. Scale 
bar 5 µm.  
 
This peptide was also able to label DNA replication sites. In Figure 3.11 it is shown the 
nucleus of cells expressing GFP tagged PCNA along different stages of the cell cycle. The 
PIP added to the extracellular media was able to reach the interior of living cells, co-localize 
with PCNA at replication sites and distinctively label replicating cells at different stages of the 
DNA synthesis phase (S-phase). Therefore, this particular in vivo cleaved PIP marks both 
repair and replication sites. At higher concentrations though, the peptide inhibited DNA 
synthesis as measured by detecting nucleotide incorporation (Figure S2). 
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Figure 3.11. In vivo immediate labeling of DNA replication sites in S-phase. Cartoon representation of the 
experimental protocol and time-lapse snapshots obtained using confocal microscopy are illustrated. GFP tagged 
PCNA expressing cells at different cell cycle stages recognizable by the PCNA sub-nuclear patterns were 
identified and the same peptide, PL coupled to TAT peptide via disulfide bridge [TAT(-SS-)PL-R], when added to 
the extracellular media labeled the sites of active DNA replication. Scale bar 5 µm.  
 
These results also suggest that these peptides could potentially be used in the place of 
antibodies in fixed cells, which can be particularly useful for common immunostaining 
applications. In Figure 3.12 it is shown that the PL alone can be used in fixed and membrane 
permeabilized cells to label ectopically expressed (Figure 3.12A) and endogenous PCNA 
(Figure 3.12B).  
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The cell-permeable PIP (Figure S3), on the other hand, after fixation would still label repair 
but not replication sites. After fixation the peptide still marks repair sites but in the case of 
replication it got redistributed. This indicates that live cells labeled with the cell permeable 
PIP can be fixed for further postmortem analysis only for DNA repair without disrupting the 
PCNA labeling. 
 
 
Figure 3.12. PCNA interacting 
peptide (PIP) labels replication 
and repair in fixed cells. (A) 
Here replication and repair sites 
can be directly visualized in fixed 
cells without the need of 
antibodies by PL peptide [F-PL] 
in the presence of ectopically 
expressed PCNA. (B) The same 
PL peptide clearly marks the 
endogenous PCNA. Scale bar 5 
µm.  
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In Figure 3.13 it is shown that the cell permeable PIP, obtained by coupling the TAT and the 
PL peptide through the intracellular cleavable disulfide bridge, also labeled DNA replication 
and repair sites in live cells from different species. 
 
 
Figure 3.13. The cell permeable and intracellular cleavable PIP directly labels DNA replication and repair 
in different cell types and species. The PL peptide fluorescently labeled and coupled by a disulfide bridge to 
the TAT peptide was added to the extracellular media on a variety of cells as indicated, with and without laser 
microirradiation. In the absence of labeled PCNA the PIP allows a clear classification of S-phase replication 
stages and damaged DNA sites. Scale bar 5 µm.  
 
Discussion 
In this study, we designed a cell permeable peptide able to label DNA replication and repair 
sites in live cells. The strategy was essentially based on coupling a fluorescent labeled high 
affinity PCNA binder peptide (PIP) to a cell-penetrating peptide.  
When the PIPs were microinjected into the cells these peptides were able to label PCNA. 
However, none of them were able to spontaneously cross into the cells when added to the 
extracellular media. To overcome this limitation the PIPs were coupled to a cell-penetrating 
peptide. When the PIP and the cell-penetrating peptide were covalently coupled we observed 
that the peptides were able to cross the plasma membrane but the binding and labeling of 
PCNA was inhibited. At least partially, the reason for this could be that the TAT peptide 
sequence miss-localized the PIPs. The TAT peptide localizes mainly in the cytosol and 
Chapter-3.2 
 49 
nucleolus while the PIPs need to get distributed in the nucleoplasm to reach and bind to 
PCNA effectively (Martin et al., 2007).  
To this end we coupled the TAT and the PIPs via a disulfide bridge that displayed 
intracellular cleavage. This partially restored the PCNA binding of the p21-08 PIP. This 
peptide was able to translocate into the cells and label DNA damaged sites but was unable 
to label replication sites. It is possible that this is a consequence of the mutation introduced in 
the p21-08 original sequence by the addition of the cysteine amino acid. The dye linker in 
this case was also different from the microinjected version of the peptide. All these small 
changes could have potentially altered the p21-08 PIP’s binding affinity to PCNA. Although, 
the reason why the cell permeable disulfide coupled p21-08 peptide was able to label repair 
sites and not replicating sites requires further research, this could still be potentially very 
advantageous to selectively label repair sites. 
When the same design strategy was used for the PL peptide, we found that this newly 
engineered peptide was cell permeable and able to instantaneously label both DNA 
replication and repair sites in live cells.  
We observed that the PCNA labeling is transient, indicating that the PIPs are being actively 
degraded in live cells. If necessary, there are several strategies that could be further adapted 
to avoid degradation and extend the intracellular stability of these peptides, such as the 
introduction of unnatural amino acids or by using PEGylated peptides as previously 
described (Nischan et al., 2013). However, the best approach is not obvious, since as shown 
in the case of p21-08 even small modifications in the sequence can significantly alter the 
PCNA binding of these peptides. All peptides in this study contain also the “PIP degron” motif 
(Q XX (h) TD (a)(a) XXX K/R). It has been shown that although this motif enhances PCNA 
binding the last amino acid (K or R) is critical for degradation. This degradation seems to play 
a regulatory role to avoid proteins bearing this motif from blocking DNA repair (Tsanov et al., 
2014). Therefore, mutating this last amino acid offers a simple alternative route to enhance 
stability of these peptides potentially leading to a simultaneous increase in labeling and 
blocking DNA repair. 
We have shown also that labeled PL, uncoupled to the TAT peptide, can be used on fixed 
cells following standard fixation protocols. Therefore, this peptide could also be used as a 
quick PCNA marker replacing primary/secondary antibodies used in immunofluorescence 
staining methods. Peptides with high PCNA binding affinity derived from consensus motifs, 
containing the PIP box motif (such as the peptides presented here) or alternatively peptides 
containing the APIM consensus motif (Gilljam et al., 2009), possess the inherent ability to 
competitively interfere with the PCNA recruitment of replication and repair factors. Covalently 
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coupling these peptides to cell-penetrating peptides shows great potential as an effective 
route to transport these peptides and inhibit proliferative processes (see also Figure S2)  
It has been reported that both the PL and p21 peptides interfere with DNA replication. 
Therefore, they can be used as a versatile tool to potentially target proliferative diseases. 
Moreover, these cell permeable PCNA binding peptides offer interesting therapeutic venues 
to selectively mark and distinguish replication and repair. 
In summary, here we have designed the first cell permeable PCNA binding peptide that 
instantaneously labels cells undergoing DNA repair and replication across mammalian 
species.  
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 Supplementary Information 
 
 
Figure S1. Cell-permeable in vivo cleavable p21-08 (PIP) does not label replication sites. The nucleus of a 
cell expressing fluorescently labeled PCNA undergoing DNA replication. The p21-08 (PIP) is labeled with FITC 
and coupled by a disulfide bridge to the TAT peptide. The TAT peptide transports the PIP into the cell and both 
sequences get cleaved in the interior of the cells. However, after cellular uptake and cleaved from the TAT 
peptide, the PIP still does not mark replication sites labeled by PCNA. Scale bar 5 µm. 
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Figure S2. Cell-permeable PCNA marker inhibits DNA synthesis in a dose dependent manner. The [TATS-
S-PL] or [TAT] peptides is added to the cells at the concentrations indicated. BrdU thymidine analogue is added at 
100 µM final concentration for 20 minutes. Cells are fixed and BrdU incorporationdetected with an anti-BrdU 
specific antibody and DNA counterstained with DAPI. The percentage of cells positive for BrdU represents 
Sphase cells and were plotted as mean with the error bars representing the standard deviation. Experiments were 
repeated two times, with a minimum of 150 cells per condition and per experiment. Student’s T test was 
performed with *** p> 0.001. At the highest concentration of 26 µM, the PL peptide significantly inhibits DNA 
synthesis, whereas this effect is progressively reduced at lower concentrations with 6.5 µM displaying no 
significant inhibitory effect. 
 
 
Figure S3. Cell-permeable PCNA marker redistributes upon fixation but it still labels repair sites. The 
[TAT-S-S-PL] peptide is added to the PCNA expressing cells with the previously described procedure and is 
found to clearly mark the replication and repair sites. To test whether it can be fixed in place for further analysis 
we added 3.7% formaldehyde to the cells. We found a redistribution of the peptide from replication sites into the 
nucleolus. Nonetheless, the peptide at the repair sites was still retained. Scale bars 5 µm.
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3.3. Live cell targeting of His-tagged proteins by multivalent N-nitrilotriacetic acid 
carrier complexes 
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Abstract 
Cell-penetrating peptide (CPP)-based delivery of molecules and cargoes has been proven to 
label endogenous proteins like PCNA in live cells as explained in the previous chapter. CPPs 
can carry a wide variety of cargoes. Our ultimate aim was to label histidine-tagged proteins in 
live cells using CPP-trisNTA (three times of Nitrilotriacetic acid) strategy. His-tag is one of the 
most widely used tag for recombinant protein expression and purification procedure. It is now 
established that the high-affinity trisNTA enables the formation of stable complexes with 
hexahistidine containing molecules. In this study, using a peptide tag artificial probe system 
we have developed a novel three-step approach for labeling His-tagged proteins. (1) An 
initial coupling step consisted of complexing oligo-histidines tagged to a CPP with 
fluorescently labeled trisNTA. (2) trisNTA-hexahistidine-CPP complex was then taken up into 
the cells via CPP, where trisNTA is reversibly uncoupled in the presence of a His-tag 
competitor ligand (intermediate uncoupling step). (3) In the final labeling step, the uncoupled, 
trisNTA was bound to His-tagged proteins overexpressed in the cells (i.e., the competitor for 
the hexahistidine of CPP). To understand whether the use of CPP constructs might influence 
the binding properties of trisNTA, we used time-lapse confocal microscopic analysis of living 
mammalian cells to visualize the uptake of the (His)6-TAT complexed with labeled trisNTA, 
and their subsequent uncoupling and cellular target labeling. The significant selectivity of the 
trisNTA for hexahistidine, as well as its stable yet reversible complex formation provides the 
basis for our aim to label histidine-tagged proteins. Here we used a His-tagged PCNA 
construct in order to label replication and repair processes in vitro. For proof of concept, we 
studied the naturally hepta-histidine-bearing protein MeCP2 in live cells. We also introduce a 
novel trisNTA-based staining approach for fixed cells, thus producing an inexpensive 
replacement for antibodies against histidines. 
 
Highlights 
• Labelled trisNTA, at safe concentrations, was used successfully in fixed cells to mark 
the localization of overexpressed His-tagged proteins (e.g., MeCP2, (His)6-GFP-
PCNA). 
• Labelled trisNTA can be used successfully in live cells to label overexpressed His-tag 
via competitive binding using His-tagged cell-penetrating peptide. 
• Labelled trisNTA, is a perfect replacement for histidine antibodies in immunostaining 
applications.  
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Introduction 
Histidine (His) tags are widely used affinity tags. Hochuli first developed purification of His-
tag proteins in 1987 (Hochuli et al., 1987). Since its development, numerous proteins or 
peptides have been purified using His-tags and applied mostly for clinical studies (Mayer et 
al., 2004). These tags are small and can be incorporated at the termini or in loop regions 
where they do not perturb the protein's structure and function. In order to visualize the His-
tagged proteins in living cells, fluorescent fusions (Tsien, 1998) can be introduced to the 
respective His-tagged constructs.  
Fluorescent proteins (FPs) are the most commonly used fluorescent tags that have enabled 
us to visualize, track, and quantify molecular events in live cells with space and time 
resolution. Despite its unquestionable value, the application of FP tags has several problems. 
The size of the tag can prevent the labeled construct from achieving its natural structure and 
function and may even sometimes lead to mis-localization (Lisenbee et al., 2003; Tavare et 
al., 2001). Wild-type versions of common FPs have a tendency to oligomerize. The pH 
sensitivity of the FPs limits their ability to image acidic regions of the cell. Overexpression of 
the tagged proteins can itself lead to a whole variety of potential artifacts. Genetic alteration 
can sometimes overcome these limitations, but this process can be laborious and time 
consuming.   
To alleviate this problem, several small molecular probes and covalent labeling (Keppler et 
al., 2003) methods are employed to specifically introduce markers for the proteins in live 
cells. Small molecular probes like NTA can be used to label proteins in vivo and can 
potentially open up new ways of studying proteins in living cells. NTA probes are comprised 
of a chromophore and a metal-ion-chelating NTA moiety, which binds reversibly and 
specifically to engineered oligohistidine sequences in the proteins of interest. The labeling of 
extracellular protein (Goldsmith et al., 2006) and structural investigation of 5HT3R 
_ENREF_15 (Guignet et al., 2004) ligand-gated ion channel with His-tags in live cells have 
already been studied using NTA probes. This NTA system has been manipulated in several 
ways such that it can be used not only for labeling purposes but also for simultaneous His-
tagged protein purification via immobilized metal affinity chromatography, surface 
immobilization for protein assay, interaction studies, and for therapeutic application 
(Janknecht et al., 1991; Kim et al., 2007). The advantages of the NTA-(His)6 interaction are 
its unique ability to be reversible and selective. However, this traditional mono-NTA approach 
for capturing histidine tagged proteins has some disadvantages like weak binding with a 
dissociation constant of 1 µM (Nieba et al., 1997), which may result in ligand decay and 
inaccurate kinetic measurements. In order to improve this NTA strategy, conventional mono-
NTA was replaced with trisNTA conjugated fluorophores. It has been shown that trisNTA 
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stably bound to oligohistidine-tagged proteins results in a complex that has a lifetime of more 
than an hour (Lata et al., 2006). Nano-molar affinity was achieved when the multivalent NTA 
was bound to His-tags (Huang et al., 2009). 
As these trisNTA probes are not cell permeable, we sought a transduction technology like 
cell penetrating peptide (i.e., trans-activator of transcription (TAT) derived from HIV that can 
carry trisNTA inside the cells). Previous data has already shown that coupling of a TAT-
derived peptide (extending from residues 37 to 72) to some proteins can allow their uptake 
into several cell lines or tissues (Vives et al., 1997). Several cargo varieties, such as drugs, 
proteins, peptides, and nucleic acids, have been transported across cell membranes using 
CPPs (Kabouridis, 2003). For our present study, we synthesized TAT peptides with a 
hexahistidine tag in the N-terminus, which can reversibly be coupled to trisNTA moieties 
conjugated to a fluorophore. The entry of the complex into the cell was facilitated via TAT, 
and labeling was achieved by reversible uncoupling of trisNTA from (His)6-TAT, thereby 
binding to the histidine tag in the protein of interest.   
As described in the previous chapter, PCNA is a protein found to be differentially expressed 
during the cell cycle (Bravo and Celis, 1980; Bravo et al., 1981; van Diest et al., 1998), and 
has been employed as a marker for cell proliferation (van Diest et al., 1998). Cancer often 
correlates with an enhanced level of PCNA, and their levels can be used as a prognostic 
marker in some cases (Czyzewska et al., 2004; Garrels and Franza, 1989; Morell-Quadreny 
et al., 1998; Naryzhny, 2008). Histidine-tagged PCNA constructs have been used to 
biochemically understand the dual role of PCNA in cell replication and repair (Fridman et al., 
2010; Kannouche et al., 2004). These His-tagged PCNA constructs were used for our 
present study, suggesting thereby to alleviating the need for further genetic modification or 
incorporation of fusion tags into these constructs. In order to broaden the applicability of this 
system, we also have successfully tested this trisNTA system for MeCP2 (Methyl CpG 
binding protein 2), a chromatin remodeling protein bearing a natural hepta-histidine peptide 
at its C-terminus. trisNTA-based stains of fixed cells have been successfully employed to 
visualize the protein localization, thus making an inexpensive replacement for histidine 
antibodies.   
    
Materials and Methods 
Synthesis 
All reaction steps were performed under microwave-irradiation using the Liberty 1 (CEM). 
The (His)6-tagged TAT49-57 peptide was synthesized using standard coupling protocols for 
microwave-assisted SPPS. The molar excess of reagents was calculated with regard to resin 
substitution. In Fmoc-deprotection, Fmoc-Rink-Amid MBHA resin was treated with 20% 
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piperidine in DMF (1x 0.5 min, 1×x 5 min, each 7.0 ml 75 °C, 54 W), followed by washing 
with DMF (7.0 mL, 4x). During coupling, the resin was treated with Fmoc-aa (5 equiv.), HBTU 
(5 equiv.), and DiPEA (10 equiv.) in DMF (5.0 mL) for 30 min at RT and 15 min at 75°C with 
a microwave power of 28 W, followed by washing with DMF (7.0 mL, 4×x). To increase the 
yield, the coupling steps were repeated twice throughout the synthesis. In cleavage and 
deprotection steps, the resin was stirred with a freshly prepared cleavage cocktail (95% TFA 
with phenol, TIPS, Milli-Q water, and EDT, 1.25% each) for 4 h at RT. The TAT49-57 peptide 
was precipitated in ice-cold Et2O (40 mL) and stored at least 15 min at -20°C. After 
centrifugation at 3000 rpm for 10 min and decantation, the pellet was washed and 
centrifuged two more times with Et2O (40 mL). The peptide was finally dissolved in tert-
BuOH/H2O (4/1, v/v), lyophilized, and purified by RP-HPLC using a gradient starting from 
water with 0% methanol and increasing the hydrophobicity to 15% methanol (both buffers 
contained 0.1% TFA) in 40 min at 1 mL/min on a C4 column. Retention time in RP-HPLC 
(column: PerfectSil C4) was 28.0 min. MALDI-TOF-MS: m/z 2992.3 (calcd. for [M – H]-: 
2592.9 C104H173N54O23S). (Synthesis protocol developed and performed by Ralph 
Wieneke) 
Cell culture  
The human cell line HeLa was cultured in Dulbecco’s modified eagle medium (DMEM) 
supplemented with 10% fetal calf serum, 50 µg/ml gentamicin and 2 mM glutamine. Mouse 
myoblasts C2C12 cells (Yaffe and Saxel, 1977) were cultured in DMEM supplemented with 
20% fetal calf serum, 50 µg/ml gentamicin and 2 mM glutamine. All cell culture materials 
were purchased from Sigma-Aldrich (Steinheim, Germany). The cell lines were grown at 
37°C in a humidified atmosphere with 5% CO2. 
Plasmids and transfection 
A hexahistidine tag was added to GFP-PCNA (Leonhardt et al., 2000), and MeCP2-cDNA 
from human was cloned into a pEGFP-C1 vector as described by (Agarwal et al., 2011). 
C2C12 cells were transfected with Amaxa (Lonza, Cologne, Germany) nucleofection 
(solution V, program B-032). 
Fluorescent labeling with trisNTA 
Cells transfected with MeCP2-GFP and (His)6-GFP-PCNA were used for 
immunofluorescence experiments and they were grown on glass coverslips. Cells were fixed 
with 3.7% formaldehyde for 10 minutes and permeabilized with 0.5% Triton for 20 minutes. 
For washing the cells, phosphate buffer saline (PBS) was used, and 200 nM trisNTA-
AlexaFluor 647 diluted in PBS was added to the cells and incubated for 1 hour at room 
temperature. Followed by gentle removal of trisNTA, cells were post fixed again with 3.7% 
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formaldehyde for 5 minutes. The DNA was stained with 4',6-diamidino-2-phenylindole 
(DAPI), followed by mounting in Mowiol 4-88 (Sigma-Aldrich Chemie). 
 
trisNTA complex uptake experiments 
C2C12 cells transfected with MeCP2-GFP were used for the live cell experiments. A 1:1 ratio 
of peptide:trisNTA complex was prepared by mixing ~9 µM (His)6 SGGG-TAT49-57 peptide 
with ~9 µM trisNTA-AlexaFluor 647 and incubating them for 40–50 minutes at room 
temperature. The complex was then added to the cells. After 20–25 minutes the solution was 
removed and the cells were washed once with media. Finally, fresh media was added to the 
cells. 
Microscopy 
Confocal microscopic images were collected using an Ultra VIEW VoX spinning disc system 
(Perkin Elmer) or a Nikon Ti microscope equipped with an oil immersion Plan-Apochromat 
×60/1.45 NA objective lens (pixel size in XY = 111 nm) with laser lines at 405 nm, 488 nm, 
561 nm, and 625 nm. During live cell experiments, cells were kept in a closed chamber 
designed to fit the microscopy stage at 30°C in a humidified atmosphere with 5% CO2 using 
the ACU control system from Olympus. DNA damage was induced by selecting a spot inside 
the nucleus that was then microirradiated with a 405 nm solid state diode laser with full laser 
power. 
 
Results 
Metal chelation based labeling strategy 
The scheme for metal chelation-based labeling is shown in Figure 3.14. The present method 
overcomes several restrictions of existing labeling methods by allowing fast, site-specific, 
reversible labeling of proteins using non-perturbing probes. This method is applicable to both 
in vitro and in vivo investigations of molecular interactions, to visualize His-tagged molecules, 
and to explain even the structure and topology of proteins.  
NTA forms a four times chelate with nickel ions, stoichiometrically. After the NTA chelation 
with the co-ordination sphere of nickel, two sites were still left free (Ni2+) to interact with the 
electron donor group of the imidazole group present in the histidines (Khan et al., 2006).  
trisNTA can be conjugated with wide range of dyes to increase its applicability.  
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Figure 3.14. Components for metal chelation-based labeling. (A) The structure of trisNTA conjugated with 
AlexaFluor 647 is shown. (B) A hexahistidine-tagged protein of interest (POI) is shown. The formation of co-
ordination bonds between the Ni2+ and nitrogen atoms in the imidazole group of histidine are shown as dotted 
lines.    
 
In vivo labeling of His-tagged proteins using cell permeable trisNTA  
As shown in Figure S2, no uptake via endocytosis was observed when trisNTA AlexaFluor 
647 was added to the cells. Rather, trisNTA stayed outside of the cells, showing no toxic 
effects up to one hour after the treatment. In order to facilitate the uptake of trisNTA, (His)6-
TAT was used as a carrier. The two moieties (trisNTA Alexa488 and (His)6-TAT) were 
incubated at room temperature to make a stable complex (Figure 3.15). Nitrogen atoms of 
the imidazole group of histidine are deprotonated to form a co-ordinate bond with the nickel 
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ion present in each NTA of the trisNTA molecule. Thanks to the TAT peptide, the complex 
penetrated the cell membrane and accumulated into the nucleolar compartment. In the 
absence of the competitor, trisNTA dissociation from the (His)6-tag in the presence of CPP is 
not favored, thus determining the staining. Also, a minimal amount of trisNTA uncoupled from 
(His)6-TAT is to be expected, due to the reducing environment of the cytoplasm. However, in 
the presence of a competitor tag in the protein of interest, significant dissociation of the 
trisNTA moiety from the carrier, CPP, and subsequent binding to the protein of interest was 
observed. Such exchange is likely to be dependent on the number of histidines present in the 
tag affecting the dissociation constant between the involved moieties (see below). 
 
 
Figure 3.15. Real time cellular uptake of trisNTA Alexa 488 complexed with His-tagged TAT. Illustrations of 
the experimental protocol are shown. The (His)6 -tagged TAT was incubated with trisNTA-Alexa 488 to form a 
complex at room temperature. The complex was added to the cells and showed uptake and localization into the 
nucleoli.    
 
Live cell labeling of overexpressed His6-GFP-PCNA was visualized in cells undergoing 
repair, replication, or no replication (Figure 3.16). Repair was studied by microirradiating the 
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transfected cells with a 405 nm laser to induce a variety of DNA damage at a specific spot. 
As a result of the DNA damage, PCNA promptly accumulated at the site of irradiation to 
initiate the repair process. Despite such pronounced accumulation, minimal trisNTA 
exchange was observed between the (His)6 tag present in the CPP and that in PCNA. This 
resulted in a mild co-localization of trisNTA with (His)6-GFP-PCNA at the irradiated spot, and 
such co-localization only lasted for a few seconds (Fig. 3.16B). In replicating cells (i.e., cells 
showing a typical PCNA replication pattern), only a minimal amount of trisNTA exchange was 
observed (Fig. 3.16C). In non-replicating cells, a partial exchange was initially observed (Fig. 
3.16D). However, at later times, the majority of trisNTA bound to (His)6-TAT and was finally 
taken into the nucleoli (Fig. 3.16E). 
It is already well known from the biochemical point of view that in NTA-His tag protein 
purification systems the His-tagged proteins bound to immobilized NTA can be eluted by the 
addition of a competitive ligand like imidazole. Similarly, in our case cells over-expressing a 
competitive ligand with a higher number of histidines than the (His)6-TAT can potentially favor 
the uncoupling of the trisNTA from the (His)6-TAT complex, facilitating the subsequent 
binding of trisNTA with the competitive ligand. Hence, we used MeCP2 bearing a natural 
heptahistidine peptide in the C-terminus of the coding region. This amino acid sequence is 
conserved among mouse, rat, and human species (Fig. 3.17A). MeCP2 accumulated in 
densely methylated pericentric heterochromatin called chromocenters (Agarwal et al., 2011). 
When the trisNTA:(His)6-TAT complex was added to the cells in the presence of the 
competitor ligand (i.e., MeCP2) with heptahistidines, trisNTA was efficiently uncoupled from 
(His)6-TAT and bound to the MeCP2, thereby showing a clear co-localization (Fig. 3.17B). 
However, the washing step was critical to avoid the excess uptake of the complex by the cell 
(Figure S1).  
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Figure 3.16. In vivo labeling of His-tagged PCNA in live cells. (A) The PCNA construct used here is illustrated 
with its respective (His)6 and GFP tags. (B) PCNA expressing cells in a non-replicating stage chosen for the repair 
experiments were microirradiated with a 405 nm laser in order to trigger recruitment of (His)6-GFP-PCNA at the 
irradiated spot. The addition of the pre-incubated complex follows. Slight co-localization of trisNTA-AlexaFluor 647 
with (His)6-GFP-PCNA was observed at the repair sites. (C) Cells undergoing replication were chosen and the 
complex was added to them. Little to no co-localization was observed. (D) In the case of non-replicating cells, the 
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trisNTA showed no nucleolar accumulation. (E) However, at later time points nucleolar accumulation was 
observed. 
 
 
Figure 3.17. In vivo labeling of heptahistidine-bearing MeCP2 in live cells. (A) The MeCP2 constructs with 
conserved histidine residues are shown. (B) Cells transfected with MeCP2-GFP showed accumulation at the 
chromocenters. 30 minutes post complex addition, trisNTA-AlexaFluor 647 dissociated from the complex and 
bound to the heptahistidine peptide of MeCP2-GFP. (C) In untransfected cells, trisNTA-AlexaFluor 647  showed 
the typical nucleolar accumulation pattern.  
 
As shown in Figure 3.18, trisNTA-AlexaFluor 647 alone was used in (His)6-GFP-PCNA or 
MeCP2-GFP transfected cells to label the sites of replication or chromocenters, respectively, 
in fixed and permeabilized cells. Early, mid, and late replication patterns of the cells 
expressing (His)6-GFP-PCNA are shown in figure 3.18A. Chromocenters in MeCP2-GFP 
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overexpressing cells were clearly labeled with trisNTA-AlexaFluor 647 (Figure 3.18B), 
thereby suggesting six histidines to be sufficient for the trisNTA binding. 
 
Figure 3.18. Fluorescent labeling of His-tagged proteins with trisNTA in fixed cells. (A) trisNTA-AlexaFluor 
647 labeled (His)6-GFP-PCNA transfected cells using the normal immunostaining procedure. (B) Similar 
procedures were adopted to label MeCP2-GFP transfected cells.  
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Discussion  
Our results made us envisage that the combinatorial use of trisNTA with (His)6-TAT  labeling 
system would be a favorable strategy to explain complex biological events involving His-
tagged proteins. We also believe that our present non-covalent labeling method would be 
useful for bio-imaging studies.  
The labeled trisNTA did not enter the cell via endocytosis (Figure S2). Efficiently trisNTA was 
taken up by the cells via TAT and accumulated into the nucleoli. This nucleolar accumulation 
must be due to positive charges of arginine and lysine residues in the TAT moiety (Jarboui et 
al., 2012; Tunnemann et al., 2006);(Figure 3.15). The trisNTA bound to the (His)6-TAT 
complex underwent uncoupling, leaving some free trisNTA. This uncoupling might have 
occurred in the reducing cellular compartments, thereby protonating the nitrogen atoms in 
the imidazole group of histidine residues tagged to TAT.   
Labeling (His)6-GFP-PCNA with trisNTA in living cells in order to visualize the repair events 
requires DNA damage induction by microirradiation with a 405 nm laser. As explained in 
Chapter 3.2, the employed laser conditions induced mixed DNA damage and led to massive 
PCNA recruitment at the irradiated site. Due to its massive recruitment, trisNTA that 
generally is uncoupled from hexahistidine tag of TAT was exchanged to a hexahistidine tag 
of PCNA at the spot of irradiation (Figure 3.16B). However, this minimal exchange was 
favored for a short duration. Very low levels of trisNTA co-localizing with (His)6-GFP-PCNA at 
the replication sites (Fig. 3.16C) were due to less PCNA localized at the sites of replication 
than at the repair sites. The labeling of MeCP2 by trisNTA in living cells was enhanced due 
to the presence of heptahistidine in its coding region, which is one residue longer than its 
complexing cognate carrier (His)6-TAT (Figure 3.17). The dissociation constant for trisNTA 
binding to a higher number of histidines should be lower than binding to a lower number of 
histidines. Hence, better uncoupling and labeling was achieved with MeCP2, the latter having 
a higher number of histidines than PCNA.  
However, the fluorescent labeling with trisNTA convinced us that in the absence of the 
complexing partner carrier (His)6-TAT, the expression levels of the (His)6-GFP-PCNA and 
MeCP2 were sufficient for the trisNTA to label them in fixed and permeabilized cells (Fig. 
3.18A, 3.18B). The fluorescent labeling with trisNTA for His-tagged proteins in vitro was a 
major breakthrough that alleviates the need for using antibodies against histidine. This 
procedure is a quick and cheap way to examine expression levels and protein localization. 
However biochemists who extensively use His-tags for protein purification, binding assays 
can now use this trisNTA strategy to label the proteins of interest in live and fixed cells, 
thereby bypassing the need for cloning fluorescent fusion constructs.   
From the experimental observations made so far, there are two major factors that seem to 
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favor trisNTA exchange and subsequent in vivo binding in living cells: (a) increasing the 
number of histidine residues can improve trisNTA binding as observed in the case of MeCP2 
and (b) despite having same number of histidines, a higher concentration of (His)6-GFP-
PCNA at irradiated sites leads to minimal exchange of trisNTA from (His)6-TAT and a 
similarly high concentration of MeCP2 in the chromocenters facilitated the better binding of 
trisNTA. It is shown in Figure S3 that at safe concentrations of trisNTA, it can bind to as low 
as 0.4 picogram of MeCP2/cell.  
Further improvements like altering the number of histidine tags for the protein of interest and 
multivalent NTA would be of great interest to optimize the efficacy of this system in living 
cells. The exchange efficiency of trisNTA from (His)6-TAT to our protein of interest can be 
better evaluated by tagging the TAT and trisNTA with different fluorophores. This way one 
could quantify the TAT label in the nucleoli and the trisNTA label which is bound to the His-
tagged proteins in nuclei or cytoplasm based on their localization. Moreover, trisNTA probes 
are economical, quickly produced, and biocompatible, thus facilitating the quick analysis of 
various structural and functional elements in the cell. 
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Supplementary information 
 
Figure S1. Time lapse of trisNTA labeling MeCP2. The preincubated complex was added to the cells 
transfected with MeCP2-GFP. Washing step was included to reduce the background and the TAT-mediated 
toxicity to the cells. 
 
 
Figure S2. 
trisNTA is 
not cell 
permeable. 
Time lapse 
images of 
labeled 
trisNTA 
show that 
when it is 
added to 
cells, 
trisNTA-
AlexaFluor 
647 alone 
is not able 
to penetrate 
into cells. 
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Figure S3. Minimal 
His-tagged protein 
concentration was 
detected using safe 
amounts of trisNTA. 
(A) MeCP2 transfected 
cells were labeled with 
200 nM trisNTAAF647 
and DNA 
counterstained with 
DAPI. Imaging was 
performed using an 
Operetta automated 
imaging system (Perkin 
Elmer, 
Buckinghamshire, UK). 
(B) Image analysis was 
performed as described 
in the workflow. (C) 
Exemplary images with 
different MeCP2 levels 
are shown with the 
corresponding DNA 
stain and trisNTA labels 
and magnified  (D). 
FIuorescence intensitiy 
(FI) profiles were used 
to score specific 
trisNTA labels of 
MeCP2 distribution.  
(E) A total FI of trisNTA 
and MeCP2 are plotted 
based on a purified 
MeCP2 calibration 
curve, specifically 
labeled by trisNTA (as 
shown in the line 
profiles in the 
concentration needed. 
Scale bar: 5µm. 
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3.4. Role of H2A variants in DNA damage susceptibility, replication and repair 
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Abstract 
Chromatin is structured such that it has special histones called variant histones.  
Variant histones have evolved to perform functions that are unique from the canonical core 
histones, including specific histone modifications, chromatin remodeling, transcriptional 
regulation, protection against DNA damage, and DNA repair. The precise role of histones in 
these processes remains largely unclear.  
Here we focus on H2A.Bbd, a histone H2A variant found in mammals but not in 
invertebrates. This rapidly evolving histone variant is studied in comparison with its canonical 
counterpart, H2A. We find H2A.Bbd is localized transiently at the sites of active DNA 
synthesis during S-phase and DNA repair. Decondensed or relaxed chromatin conformations 
could be one potential reason for the increased number of fragile sites that have a higher 
likelihood of being damaged. Taken together, our data suggest that H2A.Bbd is enriched in 
sites of active DNA replication leading to a shortened S phase duration and more open 
chromatin conformation, which may result in increased DNA damage susceptibility. H2A.Bbd 
overexpressing cells have a shorter S-phase duration and increased DNA damage 
sensitivity; these two phenotypes are observed in Hodgkin’s lymphoma cells that aberrantly 
overexpress this histone.  
 
Highlights 
• H2A.Bbd accumulates at sites of DNA replication/repair. 
• H2A.Bbd loads faster than H2A at damaged sites. 
• H2A.Bbd overexpressing cells are sensitive to UV-C compared to H2A 
overexpressing cells.  
• H2A.Bbd overexpressing cells exhibit shorter S-Phase duration. 
• Similarly, Hodgkin’s lymphoma cell lines, with high H2A.Bbd mRNA levels, replicate 
faster. 
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Introduction  
Genomic DNA is packaged and condensed into chromatin in a dynamic manner. Higher 
order structures of chromatin plays an important role in gene regulation (Bian & Belmont, 
2012; Wolffe & Guschin, 2000). The nucleosome is the elementary unit of the chromatin of 
eukaryotic genomic DNA. Nucleosomes are stable in vitro but are dynamically arranged 
during the transcription, replication, recombination, and repair processes (Groth et al., 2007; 
Grunstein, 1997; Wolffe, 1997). Nucleosomal compartments contain core canonical histones 
like H2A, H2B, H3, and H4, which are positively charged and form dimers (Sperling & Bustin, 
1976). Two copies of each core histone form an octameric structure, from two dimers of 
H2A/H2B with the closest central H3/H4 tetramer, which can package about 147 bps of DNA 
to form the nucleosome core particle (NCP) (Richmond, 1999). Histone variants are non-
allelic protein isoforms of canonical histones that differ in their sequence and their expression 
pattern (Marzluff et al., 2002). Canonical histones are synthesized during the S phase of the 
cell cycle, whereas the expression of histone variants is replication independent and takes 
place throughout the cell cycle (Nelson et al., 2002). Core histones are subjected to post- 
translational modifications, which are largely reversible, like acetylation, methylation, 
ubiquitination, poly- ADP ribosylation, biotynylation and phosphorylation. These modifications 
are observed in the N-terminal tails and also in histone fold domains. Chromatin structures 
that comprise nucleosomal units can undergo morphological and structural changes. Such 
changes can lead to several fatal diseases, including cancer. Generally, modifications within 
the N-terminus of the core histone can regulate chromatin compaction. However, when an 
oncogene is activated, and subsequent deactivation of a tumour suppressor gene may lead 
to chromatin decondensation (Herrera et al., 1996; Laitinen et al., 1990). Chromatin 
structural changes that leads to oncogenic transformation can potentially be used as 
biomarkers for e.g., it was found that EZH2, the component of the polycomb repressive 
complex 2 (PRC2), was found to be upregulated in prostrate cancer (Varambally et al., 
2002). However, past studies showed that the overexpression of some of the histones and 
their variants are implicated with cancer, for e.g., overexpression of histones like H3.3 was 
found in carcinoma of esophagus, H2A.1 in hepatocarcinogenesis	   and	   phosphorylated 
histone H3 in gastric adenocarcinoma, (Graber et al., 1996; Khare et al., 2011; Takahashi et 
al., 2006; Vardabasso et al., 2014).  
Hence, the properties of histone variants is important for the better understanding of disease 
development. One of the variants of histone H2A is H2A.Bbd. H2A.Bbd or H2A Barr body 
depleted got this name as it is found excluded from the Barr body (Chadwick & Willard, 
2001). H2A.Bbd is highly expressed in spermatogenic fractions of mammalian testis 
(Ishibashi et al., 2010). This histone variant lacks the acidic patch in the C-terminus found in 
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canonical histones. Accordingly, it has the tendency to relax or destabilize the nucleosome 
core particle. H2A.Bbd containing nucleosomes protect only 120-130 bps of DNA, whereas 
147 bps are protected by canonical nucleosomes that contains histones like H2A (Bao et al., 
2004; Chodaparambil et al., 2007; Doyen et al., 2006; Kamakaka & Biggins, 2005). 
Nucleosomes containing H2A.Bbd form specific chromatin structures that are characterized 
by smaller DNA protection and nucleosome spacing and are mostly found within actively 
transcribed genes (Tolstorukov et al., 2012). Moreover, since H2A.Bbd does not have any 
lysine residue at its C-terminus, it cannot be ubiquitinated. Canonical H2A, on the other 
hand, is ubiquitinated at the K119 site, which is a transcription repression mark (Cao et al., 
2005). Due to the absence of this transcription repression mark at the K119 site, H2A.Bbd 
positively regulates transcription. Increased expression of different histone variants has been 
found in multiple types of cancer. As H2A.Bbd plays a role in regulating the key cellular and 
developmental processes, the deregulation of histone variant expression has been linked to 
tumor initiation and progression. H2A.Bbd transcripts are found in high levels in Hodgkin 
Lymphoma cell lines as described in (Winkler et al., 2012), pointing to its potential relevance 
to cancer. While the biophysical characteristics of this histone variant are well-characterized 
in vitro, deep understanding of its cellular processes, such as DNA damage, replication, 
repair and its localization, is still lacking. Previous studies already have shown that H2A.Bbd 
is overexpressed in male spermiogenic fractions as described in (Ishibashi et al., 2010). Still, 
several potential roles of H2A.Bbd remains unclear. In this study, we focused on 
understanding the histone variant H2A.Bbd, and their relevance in disease, particularly 
cancer. To this end, we overexpressed H2A.Bbd in mouse embryonic fibroblasts (MEFs) and 
elucidated their radiation sensitivity, proliferation behaviour, S-phase duration, and their 
relevance towards pathophysiological phenotypes (i.e., Hodgkin’s lymphoma).   
 
Materials and Methods 
Cell culture, transfection and live cell imaging 
Female MEF cells were grown in Dulbecco's Modified Eagle Medium (DMEM) supplemented 
with 10% fetal calf serum (Sigma) and 50 µg/ml gentamicin and 2 mM glutamine. Human 
Hodgkin’s lymphoma (HL) cell lines L-428 (Drexler et al., 1986), L1236 (Wolf et al., 1996), 
KM-H2 (Kamesaki et al., 1986), HDLM-2 (Drexler et al., 1986), L-540 (Diehl et al., 1981) 
were obtained from Deutsche Sammlung für Mikroorganismen und Zellkulturen 
(Braunschweig, Germany). Epstein-Barr virus-immortalized cell lines (LCL) and Peripheral 
blood mononuclear cells (PBMCs) from healthy donors and patients with HL were isolated as 
described in (Foell et al., 2008) and were cultured in RPMI 1640 (Sigma) supplemented with 
10% fetal calf serum (Sigma), 50 µg/ml gentamicin, and 4 mM glutamine. For stable cell 
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lines, MEF cells were transfected with GFP-H2A.Bbd and GFP-H2A expression plasmids 
using FuGENE® HD transfection reagent (Roche) according to the manufacturer's 
instructions. Stable cell lines were selected using G418 (PAA) at a concentration of 600 
µg/ml. For live cell imaging mouse embryonic fibroblast (MEFs) cells stably expressing GFP-
H2A.Bbd were transfected with mRFP-PCNA (Ref: Sporbert et al. 2005) using Amaxa 
nucleofection protocol, was used as described in (Casas-Delucchi et al. (2012).  
Nucleofected cells were plated on a p35 glass bottomed dish and grown under standard 
conditions. 3D stacks were acquired at 20-minute intervals overnight. Time lapse imaging 
was carried out on a UltraVIEW VoX spinning disc confocal system (PerkinElmer, UK) in a 
closed live-cell microscopy chamber (ACU control, Olympus, Japan) heated to 37°C, with 5% 
CO2, and 60% humidity, mounted on a Nikon Ti microscope (Nikon, Japan), using a 60x/1.45 
NA Plan apochromat oil immersion objective lens. Images were obtained with a cooled 14-bit 
EMCCD camera (C9100-50, CamLink). Maximum intensity Z-projections were assembled 
into videos and annotated using ImageJ (http://rsb.info.nih.gov/ij/). 
Microirradiation experiments 
A Nikon Ti spinning disc microscope was used for creating laser-induced DNA damage. A 
405 nm diode laser set to 100% transmission was used for creating DNA double strand 
breaks. Spots of 1 µm in diameter were selected inside the nucleus and were microirradiated 
with 1 mJ energy. Images were acquired pre- and post-microirradiation. For PCNA 
independent repair induction, with 561 nm laser DNA damage were induced at 66 mJ energy 
as described (Muster, 2014). 
UV-C irradiation experiments 
To assess the sensitivity of H2A.Bbd overexpressing cells to UV-C light, cells were irradiated 
with a UV-C (254 nm) source containing short wave lamps (Amersham Biosciences) at a 
power of 5.8 watt. To induce damage, media was removed from the cells and irradiation was 
performed globally for 10 seconds with a total dosage of 1 mJ/cm2. Control cells were not 
irradiated. 
Immunofluorescence  
Cells were grown on glass coverslips and fixed with 3.7% formaldehyde for 10 minutes at 
room temperature followed by a combined permeablization and DNA denaturation step with 
ice cold 0.7% Triton X-100/ 0.4 N HCL/ PBS for 10 minutes. To block unspecific antibody 
signal, the cells were incubated with 4% BSA for 30 minutes at room temperature. 
Immunostaining of CPD was performed by incubating the cells with monoclonal anti-CPD 
antibody (Kamiya Biomedical Company, Cat no: MC-062) at a dilution of 1:200 in BSA for 1 
hour at room temperature. For detection, cells were incubated with polyclonal antibody anti-
mouse IgG coupled to Cy3 (Jackson Laboratories, Cat no: 715-165-151) at a dilution of 
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1:330 for 1 hour at room temperature. The DNA content was stained with 4',6-diamidino-2-
phenylindole (DAPI) and finally mounted in Mowiol 4-88 (Sigma-Aldrich Chemie).  
In situ replication labeling  
To visualize newly synthesized DNA, cells grown on coverslips were pulse labeled with 100 
µM 5-bromo-2′-deoxyuridine (BrdU, Sigma-Aldrich) and either fixed immediately or chased 
for the indicated time in pre-warmed medium supplemented with 200 µM thymidine. Cells 
were fixed with 3.7 % formaldehyde for 10 minutes and permeabilized with 0.5 % Triton X-
100 for 20 minutes. BrdU detection was performed with rat-anti-BrdU (Gentaur, Cat no: 
OBT0030CX, dilution 1:100) in the presence of DNaseI for 1 hour at 37°C.  
Chromatin manipulation assay 
Cells were grown in DMEM medium supplemented with 10% fetal calf serum, 2 mM L-
glutamine, 5 g/ml gentamycin. Hypercondensation medium was composed of a dilution of 
10X PBS (1.4 M NaCl, 26.8 mM KCl, 101.4 mM Na2HPO4.2H2O, 14.6 mM KH2PO4) that were 
diluted within growth medium to yield dilutions of 4X, 2X, and 1X PBS separately. Cells were 
treated with the different hypercondensation media for 15 minutes to achieve chromatin 
condensation as described in (Martin & Cardoso, 2010). Following this, cells with 
hypercondensed chromatin were irradiated with UV-C irradiation, as described above.  
Western blot analysis 
MEFs transfected with GFP-histone variant and Hodgkin’s lymphoma (HL) cell lines were 
incubated with 0.1% Triton in PBS supplemented with proteinase inhibitor for 10 min at 4°◦C. 
After centrifugation at 3000 rpm, the nuclear pellet was resuspended in 1X PBS 
supplemented with proteinase inhibitors, and the DNA was digested with Benzonase (VWR) 
for 15 min at 37°C. 2X Laemmli buffer was added to the suspension of nuclei and heated for 
15 min at 95°C. For the western blot antibodies like anti-GFP antibody, which was a mixture 
of two mouse anti-GFP monoclonal antibodies (Roche), was used at a dilution of 1:1000, the 
anti-H3 antibody (Abcam ab1719) was used at a concentration of 1:5000, and the H2A.Bbd 
antibody (Millipore polyclonal) was used at a dilution of 1:1000. HRP coupled secondary 
antibodies were used at a dilution of 1:5000, and detection was performed using ECL 
chemiluminescent reagents (GE Healthcare Life Sciences). Protocol from Ms. Viola Sansoni. 
Quantitative reverse transcription-polymerase chain reaction 
RNA from HL cell lines and peripheral blood mononuclear cells (PBMCs) was isolated using 
Trizol reagent (Invitrogen, Karlsruhe, Germany) following the manufacturer’s protocol. After 
reverse transcription of 2 µg of RNA, quantitative reverse transcription-polymerase chain 
reaction (qRT-PCR) was performed as described in (Neumann et al., 2010). The following 
primer combinations were used: for actin beta (ACTB), 5′-ggc atc gtg atg gac tcc g-3′ and 5′ -
gct gga agg tgg aca gcg a-3′ and; for H2A.Bbd,: 5′ -tcg ttt tca gtg agc cag gt-3′ and 5′-cag aat 
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taa tga agg ccc aag-3′. Quantification of gene expression was performed using the 2−ΔΔCt 
method [H], and for comparative analysis the median Dct value from PBMC (21 independent 
donors) was set as one. Protocol from Mr. Martin Staege.  
CPD quantification 
The levels of DNA damage were calculated from confocal 3D images of CPD stainings and 
DNA was counterstained with DAPI using the image analysis platform Priithon 
(http://code.google.com/p/priithon/). The DAPI images were used to create 3D nuclear masks 
by applying a median filter (sigma = 5 px) and segmenting the filtered images using 
automatic thresholding (Otsu, 1979). The integrated CPD signal within the nuclear mask was 
divided by the mask volume to obtain the mean CPD intensity in each nucleus.  
Microirradiation data analysis 
For evaluation kinetics of the accumulation of histones from microirradiation data, a minimum 
of 8–-10 cells was analyzed. The easyFRAP software package (Rapsomaniki et al., 2012) 
whose function include, data visualization, normalization of the raw recovery curves, and 
curve fitting. This software allows low quality data to be excluded and quantitative information 
to be extracted and saved. Raw intensities of bleached area (ROI1), the whole cell (ROI2), 
and a background area (ROI3) and the corresponding time-points were calculated using a 
custom made ImageJ macro. Results were saved in .csv, .txt, and .xls file formats. The 
easyFRAP software package computes the recovery curves, according to the formula of 
double normalization, and maximal accumulation represents the highest ratio from each 
experiment.  
 
Results  
H2A.Bbd localizes at the sites of DNA synthesis 
To understand the composition and function of H2A.Bbd containing chromatin, female MEFs 
stably expressing GFP-H2A.Bbd and GFP-H2A were generated. These cell lines expressing 
relevant histones at similar levels were confirmed by fluorescence activated cell sorting. In 
order to characterize the nuclear distribution of GFP-H2A.Bbd, we used light microscopy to 
visualize the specific GFP-H2A.Bbd localization pattern. We were able to show that GFP-
H2A.Bbd is associated with the replication machinery by co-localizing and following mRFP-
PCNA during replication and repair as shown in Figure 3.19B. Co-localization of H2A.Bbd 
with the endogenous PCNA was confirmed with the addition of PCNA biomarker, as shown 
in Figures 3.19C and 3.19D with the corresponding line profiles. To check if H2A.Bbd 
accumulation at the microirradiated sites is PCNA dependent, H2A.Bbd-overexpressing 
MEFs were microirradiated with 405 nm and 561 nm lasers. The DSBs generated by laser 
microirradiation are more similar to endogenous DSBs. DNA damage induction by irradiation 
at a 561 nm wavelength does not lead to accumulation of PCNA. No recruitment of H2A.Bbd 
Chapter-3.4 
 80 
was observed with a 561 nm laser, that does not recruit PCNA. The processive DNA 
synthesis-related factor PCNA only accumulates at sites of 405 nm laser induced DNA 
damage. Accordingly, PCNA was recruited at the sites of repair with the 405 nm laser but not 
with 561 nm laser as described (Muster, 2014). The maximum accumulation of the H2A.Bbd 
is shown in Figure 3.19E when the DNA damage was induced by these different types of 
laser.  
To check the mobility of H2A.Bbd with respect to H2A at the repair sites, the corresponding 
cell lines were microirradiated with a 405 nm laser. In comparison to the canonical histone 
H2A, H2A.Bbd was highly mobile at the repair sites caused by 405 nm laser. The time lapse 
images and the recruitment kinetics clearly demonstrate the high mobility of H2A.Bbd in 
Figure 3.20A and B. In contrast, the canonical GFP-H2A remained relatively immobile under 
the same conditions. 
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Figure 3.19. H2A.Bbd is localized at the sites of DNA synthesis and repair. (A) Cells overexpressing 
H2A.Bbd were co-transfected with mRFP-PCNA and microirradiated with a 405 nm laser. At the sites of repair it 
was found that H2A. Bbd localizes and follows PCNA. (B) Time Lapse images of H2A.Bbd following mRFP-PCNA 
during S-phase are shown. (C) H2A.Bbd overexpressing MEFs alone were microirradiated with 405 nm laser and 
found to co-localize with endogenous PCNA, which is confirmed by our PCNA biomarker (i.e., TAT-S-S-PL-R or 
PCNA interacting Peptide [PIP], as described in Chapter-3.3). (D) H2A.Bbd was found to co-localize with the 
endogenous PCNA at the replication sites. The line intensity plots of H2A.Bbd (green) and PIP (red) show a 
positive correlation. (E) Maximum accumulation of H2A.Bbd upon DNA double strand breaks induced with 405 nm 
and 561 nm laser is shown. Error bar represents standard deviation. (Scale bar: 5 µm) 
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Figure 3.20. Mobility of H2A.Bbd at the microirradiated sites. (A) Cells expressing GFP-H2A or GFP-H2A.Bbd 
were imaged and compared before and after microirradiation with 405 nm laser. (B) Quantification of the 
microirradiation data computed by easyFRAP is shown. Values represent mean and error bars represent 
standard deviation.   
 
H2A.Bbd overexpressing cells are sensitive to non-ionizing radiation 
In order to check the sensitivity of H2A.Bbd overexpressing cells in comparison with H2A 
overexpressing cells to non-ionizing radiation, the cells were exposed to UV-C and 
subsequently tested for the CPD generation through immunostaining. It was found that 
H2A.Bbd overexpressing cells showed increased sensitivity to UV-C than H2A 
overexpressing ones. The amount of CPD was analyzed via custom Priithon code (Figure 
3.21). 
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Figure 3.21. Radiation sensitivity of H2A.Bbd overexpressing cell lines. MEFs overexpressing H2A.Bbd and 
H2A were subjected to UV-C irradiation of 1 mJ/cm2. Quantification of the whole cell nuclear intensity was double 
normalized to the H2A counterpart and the unirradiated cells. Error bars represent 95% confidence intervals. (***: 
p < 0.001, calculated using two-tailed t-tests) 
 
Different levels of chromatin condensation influence DNA damage sensitivity in H2A 
variants 
To elucidate the increased DNA damage sensitivity in H2A.Bbd over-expressing cells and to 
test whether changes in higher-order chromatin structure caused by H2A.Bbd over-
expression have an influence in the induction of CPDs, we developed a system for chromatin 
manipulation that uses a hypertonic treatment as described in (Martin et al., 2010;) Figure 
3.22. Using this assay, the chromatin condensation levels of H2A.Bbd over-expressing cells 
were reversed to similar levels of H2A control cells. We found that H2A.Bbd overexpressing 
cells with condensed chromatin were mildly resistant to DNA damage.   
 
 
Figure 3.22. Radiation sensitivity 
at different condensation levels 
of the histone variants. Chromatin 
of the MEFs containing H2A.Bbd 
were treated with different 
concentration of 1X, 2X, 3X, or 4X 
PBS, and then they were subjected 
to UV-C irradiation with the same 
dose. Then the relative CPD 
intensity was measured. Error bars 
represent 95% confidence 
intervals. (***: p < 0.001, calculated 
using two-tailed t-tests) 
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H2A.Bbd is over-expressed in Hodgkin’s lymphoma cancer cells. 
As H2A.Bbd actively localizes at the sites of DNA replication, we wanted to know if the 
expression of H2A.Bbd had any influence on the replication timing. For that we used BrdU 
pulse for the H2A.Bbd and H2A overexpressing cells, and then from BrdU positive cells, we 
calculated the percentage of S-phase cells. Doubling time was measured in both the cell 
lines. S-phase duration was calculated by multiplying doubling time with the percentage of S-
phase cells. Here we found a 20% shorter S-phase duration in the GFP-H2A.Bbd-expressing 
MEFs compared to the GFP-H2A expressing cells as shown in Figure 3.23A.  
A shorter S-phase duration and its increased DNA damage susceptibility are important 
features of cancer cells. In previous studies the analysis of Gene Expression Omnibus 
microarray data sets from Hodgkin’s lymphoma cell line samples showed increased levels of 
H2A.Bbd RNA in comparison with normal tissue (Winkler et al., 2012). Consistent with this 
finding, chromatin isolated from HL cells contains much higher levels of H2A.Bbd than 
control cells, where H2A.Bbd is not detectable. Interestingly, the total levels of H2A.Bbd vary 
substantially in different HL lines with the lines containing highly expressed H2A.Bbd having 
a shorter doubling time than the ones with lower expression levels. This suggests that 
H2A.Bbd overexpression might have a similar effect in MEFs and tumor cells (Figure 3.23). 
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Figure 3.23. 
Proliferation behavior 
of H2A.Bbd-
overexpressing cells 
lines. (A) Doubling time 
and S-phase progression 
was compared between 
the MEFs 
overexpressing GFP-
H2A.Bbd and GFP-H2A. 
Error bars represent 95% 
confidence intervals. (*: p 
< 0.05, calculated using 
two-tailed t-tests) 
(B) Hodgkin’s lymphoma 
cells expressing different 
levels of H2A.Bbd have 
different. Error bars 
represent standard 
deviation. (C) Expression 
analysis of H2A.Bbd in 
HL cells and control cells 
using qRT-PCR is 
summarized. For this 
experiment cDNA from 
HL cell lines and normal 
PBMC were used as 
templates for quantitative 
PCR. For calculation of 
relative expression 
values, actin beta was 
used as housekeeping 
control and the median 
expression in normal 
PBMC was set as 1 
(Data from Viola 
Sansoni). (D) Western 
blots of Hodgkin's 
lymphoma cells (HL) and 
control cell lines were 
tested for H2A.Bbd using 
western blot analysis. 
Histone H3 was used as 
a control for Ponceau 
staining (Data from 
Martin Staege). 
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Discussion 
Time-lapse microscopy data revealed that GFP-H2A.Bbd is incorporated into chromatin just 
after DNA replication and repair, and is shortly thereafter replaced by the canonical H2A. 
This observation is consistent with the reduced stability of nucleosomal H2A.Bbd in live cells 
as described in (Gautier et al., 2004) using FRAP (Fluorescent recovery after 
photobleaching). Here the TAT-S-S-PL described in Chapter-3.3 was used to mark the sites 
where the endogenous PCNA is localized. This biomarker allowed us to recognize the 
localization of H2A.Bbd along with endogenous and ectopically expressed levels of PCNA. 
Clearly, the live cell data shows that H2A.Bbd interacts with PCNA at repair sites, thus 
validating real time biochemical data from mass spec as described (Sansoni et al. 2014).  
H2A.Bbd nucleosomes, which have a more relaxed structure, are proposed to be less stable 
and undergo transcription more quickly than conventional nucleosomes, and they are 
resistant to remodeling by SWI/SNF (SWItch/Sucrose NonFermentable) complexes (Doyen 
et al., 2006; Menoni et al., 2007). Also the repair of conventional, but not H2A.Bbd, 
nucleosomes was greatly facilitated by the chromatin remodeler SWI/SNF. As H2A.Bbd is 
highly expressed in spermatogenic cells, H2A.Bbd at sites of DNA replication could 
physiologically contribute to the maturation of sperm and the replacement of the canonical 
histone with protamines. Thus, H2A.Bbd is a unique histone variant that may play a key role 
in the histone-to-protamine packing.   
Furthermore, some structural and biochemical analyses studies have shown that H2A.Bbd 
possibly forms a transitional nucleosome with shorter DNA fragments during DNA replication, 
repair, and transcription (Arimura et al., 2013). Our data also show that the decondensed and 
relaxed levels of the chromatin plays a major role in exposing the DNA to damage from UV-
C. It follows from our results that lower susceptibility of DNA to damage by non-ionizing 
radiation is due to hypercondensation as well as the presence of a higher amount of proteins 
in comparison to genetically active and decondensed chromatin. Increased sensitivity and 
shorter S-phase duration are characteristics of cancer cells. Hence Hodgkin’s lymphoma 
cells tested for the expression levels of H2A.Bbd were found to proliferate faster and 
proportionally to their H2A.Bbd expression levels. The high sensitivity of HL to radiotherapy 
and its treatment strategies are deeply reviewed (Winkler et al. 2012 ; Yeoh & Mikhaeel 
2011). H2A.Bbd is specifically overexpressed in HL cell lines and the present radio-sensitivity 
data can open up new avenues for its treatment. 
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4.  Conclusion and Outlook 
Chromobody based γ-H2AX binder - bypassing the challenges 
The main objective of the Chapter-3.1 was generation and characterization of γ-H2AX 
specific VHHs used for biochemical and intracellular applications. The generated VHHs were 
tested for its usability in vitro and in vivo and were found to be functional in vitro. In addition, 
the functionality in vivo was assessed by the localization of the fluorescently tagged γ-H2AX 
VHH (chromobody) at the sites of DNA damage. The ability to identify the native proteins is 
the ultimate test for the application of VHHs in living cells as chromobody. However, during in 
vivo characterization we encountered major problems, alternative epitope recognition and 
epitope masking. These two major pitfalls are analyzed in this chapter and illustrated in 
Figure 4.1. 
 
Figure 4.1. Model for γ-H2AX binder recruitment upon epitope unmasking and alternative epitope 
recognition. Here we show that upon XRCC1 overexpression and MDC1 knockdown, the γ-H2AX binder was 
recruited at the sites of DNA damage.  
 
Diverse factors have a role on the efficient usability of VHHs for cellular applications, such as 
the selection process of VHHs. It is very important to recapitulate the most critical steps in 
the VHH generation that could have influenced the specificity of the VHHs. 
1. The solid phase panning step has numerous drawbacks concerning the way antigens are 
presented. In order to select VHHs of high specificity, for recognizing epitopes in a native 
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environment, the presentation of antigens is very crucial. It has been previously shown that 
filamentous phages have a high inclination to bind unspecifically to diversified structures. In 
order to overcome this problem, the native panning method (Jespersen et al., 2000), which 
employs recombinant antigens with native conformations, could have been employed. 2. 
When generating larger VHH libraries, the evaluation of library diversity is very complex and 
time consuming. The sequencing method, which is the most preferable way to test libraries, 
provides additional information that cannot be obtained from restriction analysis (Carmen & 
Jermutus, 2002). However, sequencing of large libraries is costly and time-consuming. 
Therefore, for the evaluation of the diversity of the VHHs, very few clones that exhibited 
diversity were analysed. Hence sequencing analysis of more clones is critical to identify the 
clones with high specificity. 3. Theoretically, it is important to carefully check  sequencing 
data for the presence of cysteine residues within complementary determining regions 
(CDRs). Previous studies show that cysteines in VHHs can form a CDR3 intraloop or an 
cysteine bridge that will stably connect CDR3 with CDR1, which eventually stabilizes the 
VHH (Davies & Riechmann, 1996). VHH regions can be successfully modeled theoretically 
(Sircar et al., 2011). Accordingly, one could improve the specificity of the antibody by 
minimising cross-reactivity, thus rendering increased binding affinity to the epitope.  
Though we could not achieve a high specific VHHs for γ-H2AX. It is still feasible to achieve 
high specific clones by trying the aforementioned steps. 
Cell penetrating peptide-based PCNA marker 
As nanobody technology is time consuming and laborious, we tried quick cell penetrating 
peptide technology in Chapter 3.2 for the development of a cell-permeable DNA replication 
and repair biomarker by targeting PCNA interactions. We initially demonstrated the usability 
and binding capacity of fluorescently labeled PCNA binding peptides by microinjection. As 
we successfully noticed the dynamic co-localization of the peptide and PCNA, we used a cell 
penetrating peptide strategy for simply carrying the PCNA binding peptide inside the cell.  
First we covalently coupled the cell penetrating peptide (TAT) with PCNA binding peptide, 
and we did not see any binding of the peptide to PCNA (Tunnemann et al., 2006). Later, we 
improved this strategy by introducing a di-sulfide bridge between the carrier and the cargo. 
We were successful, as we saw the labeling of the PCNA with the peptide (Figure 4.2).  
Conclusion and Outlook 
 92 
 
Figure 4.2. Strategies to target PCNA in living cells. Here the steps involved in labeling the PCNA are 
illustrated. The strategy described above the cell uses a disulfide bridge and the one below does not use a 
disulfide bridge between the career and the cargo.  
 
Apart from labeling studies, there is interest in developing PCNA inhibitors as they could 
serve as anti-cancer agents, because PCNA regulates DNA replication and most DNA repair 
pathways. It would be interesting to understand the therapeutic advantages of these peptides 
that have high clinical value (Stevenson, 2009). Peptides designed for the cancer-associated 
PCNA (caPCNA) isoform found mainly in tumor cells, rather than in non-tumor cells, 
successfully inhibited the growth of neuroblastoma cells (Gu et al., 2014). Studies show that 
the AlkB homologue 2 PCNA-interacting motif (APIM) peptide was  bound with the PCNA 
thereby inducing apoptosis in multiple myeloma cells (Muller et al., 2013). Hence it would be 
interesting to compare our PIP and its mutants with multiple cancer cell lines and look for an 
inhibitory effect in replication and repair to clarify its potential clinical relevance.  
Universal cell-penetrating peptide-based histidine-tag marker 
In Chapter 3.3 we extended the usability of cell-penetrating peptides for delivering small 
molecular probes (i.e., trisNTA) in order to label any histidine tagged recombinant proteins. 
The usage of His-tag in biological applications is extensive (e.g., protein purification, protein–
protein interaction assays, protein immobilization etc.). Studies on the applications of mono- 
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and multivalent NTAs showed no loss of activity or functionality of the protein of interest (Lata 
et al., 2006). His-tag is  used in biotechnological applications  like affinity purification. 
Mainly to avoid time consuming cloning procedures we used CPP technology to transport 
trisNTA into the cells and label the His-tagged proteins. 
Our approach has three main advantages for live-cell investigations: (i) it can label His-
tagged proteins of interest in living cells, (ii) a wide choice of fluorophores for trisNTA 
labeling, and (iii) a minimalistic tag (<2 kDa) minimizes loss of protein function. Organic dyes 
are flexible in their spectral range and combinatorial spectral possibilities. As they are very 
photo-stable, they are versatile enough to detect at a single-molecule level. However, our 
approach demonstrates for the first time the labeling of MeCP2 and recombinant His-tagged 
PCNA protein in living cells, as shown in Figure 4.3 with complete mechanism and highlights 
listed below.  
 
Figure 4.3. Illustration for the mechanism of trisNTA labeling His-tagged protein in living the cells. Here 
we show the four step mechanism: (A) trisNTA coupling to His-TAT and cell penetration, (B) uncoupling of His-
TAT from trisNTA, (C) labeling of His-tagged proteins by trisNTA, and (D) TAT redistributed in the nucleolus.   
 
In our present study we used histidines (n = 6, 7) in the protein of interest. However, it would 
be interesting to validate a range of histidines and also compare the efficiency of the system 
with the cyclic TATs (Lattig-Tunnemann et al., 2011) in the place of the linear TAT used in 
this study. The strategy of the previous chapter (i.e., the disulfide bridge) should be tried for 
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its versatility and efficiency in comparison with the present coupling and uncoupling method. 
Finally, the small size, great flexibility (e.g., choice of the fluorophore), quick, and 
stoichiometric labeling of this method is of great use for in vivo super-resolution microscopy 
and single-molecule tracking analysis.  
H2A.Bbd and its potential role in carcinogenesis 
In Chapter 3.4, we discussed the newly found histone variant H2A.Bbd and its participation in 
different cellular processes. Hence, its primary proteomic profile was analyzed using mass 
spectrometry by Axel Imhof and his co-workers at LMU-Munich. Their results showed that 
H2A.Bbd interacts with the DNA replication factors. In this thesis, we show that GFP-Bbd 
overexpressed in MEF cells were found to form dynamic localization at the sites of DNA 
replication and repair sites and showed high DNA damage sensitivity to non-ionizing 
radiation like UV-C. 
It has been shown that H2A.Bbd is removed from the sites of replication in less than one 
hour by a pulse chase experiment (Sansoni et al., 2014), whereas the microirradiation 
experiments showed that it was retained for more time at the sites of repair. There may be 
different residence times at the sites of repair and replication by H2A.Bbd, which is also 
characteristic of PCNA (Essers et al., 2005). Here we also show that H2A.Bbd 
overexpressing cells were more sensitive to UV-C irradiation than were H2A overexpressing 
cells.  
In order to investigate the DNA damage sensitivity we first hypothesized that the relaxed 
nature of the H2A.Bbd comprising chromatin makes an unprotected environment for radiation 
induced DNA damage. To validate our hypothesis we reversed the chromatin condensation 
levels of H2A.Bbd to behave like H2A. Upon increasing the salt levels, the chromatin was 
more condensed and got less sensitive to UV-C. Our reasoning for this DNA damage 
sensitivity of H2A.Bbd in the context of chromatin condensation is illustrated in Figure 4.4. 
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Figure 4.4. Illustration of nucleosome comprising different H2A variants and their sensitivity to UV-C. 
Here we show that H2A and H2A.Bbd comprising nucleosomes have different levels of chromatin condensation, 
and this could potentially lead to the formation of fragile or damaged sites in DNA upon UV-C irradiation. 
 
The higher sensitivity of chromatin in H2A.Bbd-overexpressing cells is probably not due to 
the simple chromatin decondensation but  the presence of a decreased amount of proteins 
protecting the DNA than more condensed chromatin.  
It was found from our data that H2A.Bbd-overexpressing cells replicate faster than H2A-
overexpressing MEFs. However, contrary results were published that showed that H2A.Bbd 
leads to cell cycle arrest and apoptosis (Goshima et al., 2014). The difference of phenotypes 
in the two studies could be attributed to the different cell types used or different levels of 
H2A.Bbd expression. To make this determination, one should express different levels of 
H2A.Bbd and see if this changes replication or apoptosis rates. It would be interesting to 
compare the radiation sensitivity data with the cells overexpressing macro H2A as it is found 
contrastingly enriched in the Barr body.    
Multiple Hodgkin’s lymphoma cell lines were found to express H2A.Bbd. It was observed that 
the cells that express high levels of H2A.Bbd replicate faster, and the literature reveals that 
HL cells have high radiosensitivity (Yeoh & Mikhaeel, 2011). From the above findings, an 
unusual presence of H2A.Bbd in somatic cells could contribute to cancer progression and 
development. On the whole, this investigation of H2A.Bbd has not only have given some 
interesting data on DNA damage sensitivity, replication, repair, and chromatin condensation 
levels but also suggests the need for further research regarding H2A.Bbd’s unique role in 
cancer and spermatogenesis. 
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5. Annex 
5.1. Abbreviations 
Bbd - Barr body depleted 
BER-  Base excision repair 
BrdU - bromodeoxyuridine 
BSA - Bovine serum albumin 
CDC - cell division cycle 
CDK- cyclin dependent kinase 
CKM- Caesin kinase 2 mutant 
DMEM - Dulbecco’s modified Eagle’s medium 
DSB - Double Strand Break 
FRAP - Fluorescence recovery after photobleaching 
GFP -  Green fluorescent protein 
H2AX  - Histone H2AX 
His - Histidine 
HL – Hodgkin’s lymphoma 
HR - Homologus recombination 
HRP-Horse radish peroxidase 
IR - Ionizing radiation 
MCM - Mini chromosome maintanence 
MDC1- Mediator of DNA damage checkpoint-1 
MeCP2 - Methyl CPG binding protein 
MEFs - Mouse embryonic fibroblast 
mRFP - Monomeric red fluorescent protein 
NER - Nucleotide excision repair 
PARP - Poly (ADP-ribose) polymerase 
PBS - Phosphate buffer saline 
PCNA - Proliferating cell nuclear antigen 
PIP- PCNA interacting peptide 
RT - Room temperature 
S-Phase - Synthesis phase 
ssDNA - Single stranded Deoxyribose nucleic acid 
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TAT - Trans activator of transcription 
trisNTA - Tris-nitrilotriacetic acids 
UV - Ultra violet 
XRCC1 or 4 - X-ray repair complementing defective repair in Chinese hamster cells 1 or 4 
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